Diet
UltraSound
Diabetes

Cancer & Biopsy
Germanium
Heart Disease
Free Radicals
IV Chelation Therapy

Vibrant Life Home Web
Family Of Three Chelation Formulas
MSM
Other VL Products
The Wednesday Letter
Frequently Asked Questions
Testimonials
Karl Loren Web


Shopping Cart

Separate Search Page
or search below


Navigation Help

Oral Chelation Therapy
Other

Ingredients
Technical
Write To Karl Loren Table Of Contents

100 Scientific Studies of the Enzyme:  Cathepsin

Cathepsin is an enzyme of great importance in bodies of all animals (and plants).  To quote from Dr. Howell, in his Book, Enzyme Nutrition.

"All animals have a proteolytic enzyme known as cathepsin, which is widely distributed in muscles and organs, yet has no known digesting function in life. After death, the body tissues become acidic, which is favorable for catheptic activity. This enzyme then functions as the prime factor in autolysis, the breakdown of cells and tissues."

Click Here to read about "autolysis" caused by cathepsin.  Read 100 studies below to learn more about cathepsin, generally.

proteolytic enzyme

also called PROTEINASE, any of a group of enzymes that break the long chainlike molecules of proteins into shorter fragments (peptides) and eventually into their components, amino acids. Proteolytic enzymes are present in bacteria and plants but are most abundant in animals. In the stomach, protein materials are attacked initially by the gastric enzyme pepsin. When the protein material is passed to the small intestine, proteins, which are only partially digested in the stomach, are further attacked by proteolytic enzymes secreted by the pancreas.

These enzymes are liberated in the small intestine from inactive precursors produced by the acinar cells in the pancreas. The precursors are called trypsinogen, chymotrypsinogen, proelastase, and procarboxypeptidase. When the pancreatic enzymes become activated in the intestine, they convert proteins into free amino acids, which are easily absorbed by the cells of the intestinal wall.

Trypsinogen is transformed to trypsin by an enzyme (enterokinase) secreted from the walls of the small intestine. Trypsin then activates the precursors of chymotrypsin, elastase, and carboxypeptidase.

The pancreas produces a protein that inhibits trypsin. It is thought that in this manner the pancreas protects itself from autodigestion.

Click here for a reference to the large number of "proteolytic enzymes."

 

Autolysis

NOUN :

The destruction of tissues or cells of an organism by the action of substances, such as enzymes, that are produced within the organism. Also called self-digestion .

OTHER FORMS:

au´´to·lyt´ic (ô´´t-lk) — ADJECTIVE

The American Heritage® Dictionary of the English Language, Fourth Edition. Copyright © 2000 by Houghton Mifflin Company. Published by the Houghton Mifflin Company. All rights reserved.

   
Search Results
Results for your query on November 27, 2000:

The first search was for the word "cathepsin" in any field of the article, and there there were 6,502different scientific studies that met that criteria.  In order to reduce the number I then searched for that same word where it was in the TITLE of the study, and where the word "function" was someone in the abstract.  This reduced the number of studies to what is shown below, 156.  Generally when the word being searched for is in the TITLE of a study, that study has more useful information on that word than when the word merely appears somewhere within the study, but not in the title. 

Search all fields for: function
Words in title only: cathepsin
Published in 1966 through 1999
Only select references with abstracts available
Show references published in English only

Documents: 1 to 100 of 156

1

Top Of Menu

Loegering DJ, et al; Plasma cathepsin activity and reticuloendothelial phagocytic function during hemorrhagic shock. (Circ Shock, 1978, Abstract available) [MEDLINE]

2 Camire RM, et al; Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding. (Biochemistry, 1998 Aug, Abstract available) [MEDLINE]
3 Travis J, et al; Human leucocyte elastase and cathepsin G: structural and functional characteristics. (Ciba Found Symp, 1979, Abstract available) [MEDLINE]
4 Dingle JT, et al; Proteoglycan-degrading enzymes. A radiochemical assay method and the detection of a new enzyme cathepsin F. (Biochem J, 1977 Dec, Abstract available) [MEDLINE]
5 Nygren H, et al; Cathepsin D: ultra-immunohistochemical localization in dentinogenesis. (Calcif Tissue Int, 1979, Abstract available) [MEDLINE]
6 Pagano M, et al; Inhibition of human liver cathepsin L by alpha 2 cysteine-proteinase inhibitor and the low-Mr cysteine proteinase inhibitor from human serum. (Biochem J, 1984 May, Abstract available) [MEDLINE]
7 Gounaris AD, et al; Cathepsin B from human renal cortex. (Biochem J, 1982 Aug, Abstract available) [MEDLINE]
8 Schwabe C; Specificity and some physical properties of cathepsin D from bovine uterus and dental pulp. (J Dent Res, 1975 Mar, Abstract available) [MEDLINE]
9 Moon KB, et al; SPI-1-dependent host range of rabbitpox virus and complex formation with cathepsin G is associated with serpin motifs. (J Virol, 1999 Nov, Abstract available) [MEDLINE]
10

Menu Position #10

Moon KB, et al; SPI-1-dependent host range of rabbitpox virus and complex formation with cathepsin G is associated with serpin motifs. (J Virol, 1999 Nov, Abstract available) [MEDLINE]

11 Galjart NJ, et al; Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. (J Biol Chem, 1991 Aug, Abstract available) [MEDLINE]
12 Nishimura Y, et al; Expression of rat cathepsin D cDNA in Saccharomyces cerevisiae: implications for intracellular targeting of cathepsin D to vacuoles. (J Biochem (Tokyo), 1995 Jul, Abstract available) [MEDLINE]
13 Afonso S, et al; The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation. (Development, 1997 Sep, Abstract available) [MEDLINE]
14 Freeman SJ, et al; Comparative effects of cathepsin inhibitors on rat embryonic development in vitro. Evidence that cathepsin D is unimportant in the proteolytic function of yolk sac. (J Embryol Exp Morphol, 1985 Apr, Abstract available) [MEDLINE]
15 Whitaker JN, et al; Immunocytochemical studies of cathepsin D in human skeletal muscle. (Ann Neurol, 1983 Feb, Abstract available) [MEDLINE]
16 Whitaker JN, et al; Changes in sciatic nerve cathepsin D after ligation or exposure to neurotoxins. (J Neuropathol Exp Neurol, 1983 Jan, Abstract available) [MEDLINE]
17 Kinlough Rathbone RL, et al; Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents. (Thromb Res, 1999 Sep, Abstract available) [MEDLINE]
18 Kinlough Rathbone RL, et al; Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents. (Thromb Res, 1999 Sep, Abstract available) [MEDLINE]
19 Kenagy RD, et al; Effects of cell density and cell proliferation on acid cholesterol esterase and cathepsin activity of cultured human skin fibroblasts. (Biochim Biophys Acta, 1983 Nov, Abstract available) [MEDLINE]
20

Menu Position #20

Kang W, et al; Identification and characterization of the Cydia pomonella granulovirus cathepsin and chitinase genes. (J Gen Virol, 1998 Sep, Abstract available) [MEDLINE]

21 Bykowska K, et al; Effects of human neutrophil elastase and cathepsin G on the reactivity of platelets with antiplatelet antibodies. (Acta Haematol Pol, 1995, Abstract available) [MEDLINE]
22 Rudenko G, et al; The atomic model of the human protective protein/cathepsin A suggests a structural basis for galactosialidosis. (Proc Natl Acad Sci U S A, 1998 Jan, Abstract available) [MEDLINE]
23 Sinha AA, et al; Localization of cathepsin B in normal and hyperplastic human prostate by immunoperoxidase and protein A-gold techniques. (Anat Rec, 1989 Mar, Abstract available) [MEDLINE]
24 Moulton BC; Progesterone and estrogen control of the response of rat uterine lysosomal cathepsin D activity to a deciduogenic stimulus. (Endocrinology, 1982 Apr, Abstract available) [MEDLINE]
25 Senatorski G, et al; Urine activity of cathepsin B, collagenase and urine excretion of TGF-beta 1 and fibronectin in membranous glomerulonephritis. (Res Exp Med (Berl), 1998 Dec, Abstract available) [MEDLINE]
26 Yonezawa S, et al; Structures at the proteolytic processing region of cathepsin D. (J Biol Chem, 1988 Nov, Abstract available) [MEDLINE]
27 Wintroub BU, et al; Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G. (Biochemistry, 1984 Jan, Abstract available) [MEDLINE]
28 Li Q, et al; Modulation of interferon gamma induced increases in cathepsin B in THP-1 cells by adrenergic agonists and antagonists. (Cell Biol Int, 1998, Abstract available) [MEDLINE]
29 Simmen RC, et al; Ontogeny, immunocytochemical localization, and biochemical properties of the pregnancy-associated uterine elastase/cathepsin-G protease inhibitor, antileukoproteinase (ALP): monospecific antibodies to a synthetic peptide recognize native ALP. (Endocrinology, 1992 Apr, Abstract available) [MEDLINE]
30

Menu Position #30

Graf M, et al; Histochemical localization of cathepsin B at the invasion front of the rabbit V2 carcinoma. (Lab Invest, 1981 Dec, Abstract available) [MEDLINE]

31 Pshezhetsky AV, et al; Direct affinity purification and supramolecular organization of human lysosomal cathepsin A. (Arch Biochem Biophys, 1994 Aug, Abstract available) [MEDLINE]
32 Singhal PC, et al; Morphine induces splenocyte apoptosis and enhanced mRNA expression of cathepsin-B. (Inflammation, 1997 Dec, Abstract available) [MEDLINE]
33 Wex T, et al; The human cathepsin F gene--a fusion product between an ancestral cathepsin and cystatin gene. (Biol Chem, 1999 Dec, Abstract available) [MEDLINE]
34 Goldschmidt TG, et al; Adsorption and helical coiling of amphipathic peptides on lipid vesicles leads to negligible protection from cathepsin B or cathepsin D. (Immunol Invest, 1993 Feb, Abstract available) [MEDLINE]
35 Guncar G, et al; Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function. (Structure, 1998 Jan, Abstract available) [MEDLINE]
36 Hasnain S, et al; Characterization of recombinant rat cathepsin B and nonglycosylated mutants expressed in yeast. New insights into the pH dependence of cathepsin B-catalyzed hydrolyses. (J Biol Chem, 1992 Mar, Abstract available) [MEDLINE]
37 Goldschmidt TG, et al; Adsorption and helical coiling of amphipathic peptides on lipid vesicles leads to negligible protection from cathepsin B or cathepsin D. (Immunol Invest, 1993 Feb, Abstract available) [MEDLINE]
38 Bruch M, et al; Dissection of laminin by cathepsin G into its long-arm and short-arm structures and localization of regions involved in calcium dependent stabilization and self-association. (Eur J Biochem, 1989 Nov, Abstract available) [MEDLINE]
39 Weksler BB, et al; Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells. (Blood, 1989 Oct, Abstract available) [MEDLINE]
40

Menu Position #40

Watorek W, et al; Neutrophil elastase and cathepsin G: structure, function, and biological control. (Adv Exp Med Biol, 1988, Abstract available) [MEDLINE]

41 Lenarcic B, et al; Cathepsin D inactivates cysteine proteinase inhibitors, cystatins. (Biochem Biophys Res Commun, 1988 Jul, Abstract available) [MEDLINE]
42 Eisenberger U, et al; Cathepsin B and L in isolated proximal tubular segments during acute and chronic proteinuria. (Ren Physiol Biochem, 1995 Mar, Abstract available) [MEDLINE]
43 Sealy L, et al; Regulation of cathepsin E expression during human B cell differentiation in vitro. (Eur J Immunol, 1996 Aug, Abstract available) [MEDLINE]
44 Arkona C, et al; Expression, subcellular distribution and plasma membrane binding of cathepsin B and gelatinases in bone metastatic tissue. (Biol Chem, 1996 Nov, Abstract available) [MEDLINE]
45 Goseki T, et al; Effects of in vitro cellular aging on alkaline phosphatase, cathepsin activities and collagen secretion of human periodontal ligament derived cells. (Mech Ageing Dev, 1996 Nov, Abstract available) [MEDLINE]
46 Groutas WC, et al; Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one. (Biochem Biophys Res Commun, 1993 Dec, Abstract available) [MEDLINE]
47 Yamazaki K, et al; Lipid-rich residual bodies and cathepsin D in the human uterus: ultrastructural and quantitative comparison between normal myometrium and leiomyoma. (J Submicrosc Cytol Pathol, 1993 Jul, Abstract available) [MEDLINE]
48 Götz B, et al; Expression and partial characterization of a cathepsin B-like enzyme (Sm31) and a proposed 'haemoglobinase' (Sm32) from Schistosoma mansoni. (Biochem J, 1993 Mar, Abstract available) [MEDLINE]
49 Scarborough PE, et al; Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling. (Protein Sci, 1993 Feb, Abstract available) [MEDLINE]
50

Menu Position #50

Berquin IM, et al; Cathepsin B expression in human tumors. (Adv Exp Med Biol, 1996, Abstract available) [MEDLINE]

51 Puri RN, et al; Thrombin- and cathepsin G-induced platelet aggregation: effect of protein kinase C inhibitors. (Anal Biochem, 1993 Apr, Abstract available) [MEDLINE]
52 Higaki J, et al; Processing of beta-amyloid precursor protein by cathepsin D. (J Biol Chem, 1996 Dec, Abstract available) [MEDLINE]
53 Leto G, et al; Cathepsin D serum mass concentrations in patients with hepatocellular carcinoma and/or liver cirrhosis. (Eur J Clin Chem Clin Biochem, 1996 Jul, Abstract available) [MEDLINE]
54 Carmona C, et al; Cathepsin L proteinase secreted by Fasciola hepatica in vitro prevents antibody-mediated eosinophil attachment to newly excysted juveniles. (Mol Biochem Parasitol, 1993 Nov, Abstract available) [MEDLINE]
55 Rochefort H, et al; Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells. (Biochimie, 1988 Jul, Abstract available) [MEDLINE]
56 Camier B, et al; Endometrial cathepsin D immunostaining throughout ovulatory and anovulatory menstrual cycles. (Hum Reprod, 1996 Feb, Abstract available) [MEDLINE]
57 Bogitsh BJ, et al; Schistosoma japonicum: immunocytochemistry of adults using heterologous antiserum to bovine cathepsin D. (Exp Parasitol, 1987 Oct, Abstract available) [MEDLINE]
58 Abraham CR, et al; Expression of cathepsin G-like and alpha 1-antichymotrypsin-like proteins in reactive astrocytes. (Brain Res, 1993 Sep, Abstract available) [MEDLINE]
59 Chan MM, et al; Expression of human cathepsin B protein in Escherichia coli. (FEBS Lett, 1988 Nov, Abstract available) [MEDLINE]
60

Menu Position #60

Deiss LP, et al; Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. (EMBO J, 1996 Aug, Abstract available) [MEDLINE]

61 Seeler BJ, et al; Monoclonal antibody toward lysosomal cathepsin B cross-reacts preferentially with distinct histone classes. (Int J Biochem, 1988, Abstract available) [MEDLINE]
62 Authier F, et al; Negative regulation of epidermal growth factor signaling by selective proteolytic mechanisms in the endosome mediated by cathepsin B. (J Biol Chem, 1999 Nov, Abstract available) [MEDLINE]
63 Gibson TL, et al; Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases. (Growth Horm IGF Res, 1999 Aug, Abstract available) [MEDLINE]
64 Freiss G, et al; Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells. (Cancer Res, 1988 Jul, Abstract available) [MEDLINE]
65 Toomes C, et al; Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis [see comments] (Nat Genet, 1999 Dec, Abstract available) [MEDLINE]
66 Gowen M, et al; Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. (J Bone Miner Res, 1999 Oct, Abstract available) [MEDLINE]
67 Tisljar K, et al; Cathepsin J, a novel murine cysteine protease of the papain family with a placenta-restricted expression. (FEBS Lett, 1999 Oct, Abstract available) [MEDLINE]
68 Yokota S, et al; Immunocytochemical localization of cathepsin D in lysosomes of cortical collecting tubule cells of the rat kidney. (J Histochem Cytochem, 1985 Mar, Abstract available) [MEDLINE]
69 Neves FA, et al; Cathepsin B is a prorenin processing enzyme. (Hypertension, 1996 Mar, Abstract available) [MEDLINE]
70

Menu Position #70

Gowen M, et al; Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. (J Bone Miner Res, 1999 Oct, Abstract available) [MEDLINE]

71 Cavaillès V, et al; Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. (Proc Natl Acad Sci U S A, 1993 Jan, Abstract available) [MEDLINE]
72 Peterson MW, et al; Neutrophil cathepsin G increases calcium flux and inositol polyphosphate production in cultured endothelial cells. (J Immunol, 1989 Jul, Abstract available) [MEDLINE]
73 Tisljar K, et al; Cathepsin J, a novel murine cysteine protease of the papain family with a placenta-restricted expression. (FEBS Lett, 1999 Oct, Abstract available) [MEDLINE]
74 Bennett K, et al; Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. (Eur J Immunol, 1992 Jun, Abstract available) [MEDLINE]
75 Nilsen Hamilton M, et al; Regulation of the expression of mitogen-regulated protein (MRP; proliferin) and cathepsin L in cultured cells and in the murine placenta. (Mol Cell Endocrinol, 1991 May, Abstract available) [MEDLINE]
76 Hamilton RT, et al; Developmental expression of cathepsin L and c-rasHa in the mouse placenta. (Mol Reprod Dev, 1991 Dec, Abstract available) [MEDLINE]
77 Ioachim E, et al; Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation. (Anticancer Res, 1999 May, Abstract available) [MEDLINE]
78 Garwicz D, et al; Human cathepsin G lacking functional glycosylation site is proteolytically processed and targeted for storage in granules after transfection to the rat basophilic/mast cell line RBL or the murine myeloid cell line 32D. (J Biol Chem, 1995 Nov, Abstract available) [MEDLINE]
79 Naganawa Y, et al; Stable expression of protective protein/cathepsin A-green fluorescent protein fusion genes in a fibroblastic cell line from a galactosialidosis patient. Model system for revealing the intracellular transport of normal and mutated lysosomal enzymes. (Biochem J, 1999 Jun, Abstract available) [MEDLINE]
80

Menu Position #80

Ikeda K, et al; Inhibitory effect of thiols on the degradation of albumin by human spleen cathepsin D. (Biochem Int, 1990, Abstract available) [MEDLINE]

81 Wang B, et al; Human cathepsin F. Molecular cloning, functional expression, tissue localization, and enzymatic characterization. (J Biol Chem, 1998 Nov, Abstract available) [MEDLINE]
82 Abbott RE, et al; Augmented inflammatory responses and altered wound healing in cathepsin G-deficient mice. (Arch Surg, 1998 Sep, Abstract available) [MEDLINE]
83 Yavin EJ, et al; Peptides derived from human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and cathepsin G: use of overlapping peptide sequences to identify a unique inhibitor. (J Pept Res, 1998 Apr, Abstract available) [MEDLINE]
84 Smith SM, et al; Activity and deletion analysis of recombinant human cathepsin L expressed in Escherichia coli. (J Biol Chem, 1989 Dec, Abstract available) [MEDLINE]
85 Gullberg U, et al; Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL. (J Biol Chem, 1995 May, Abstract available) [MEDLINE]
86 Hase Yamazaki T, et al; Stimulation of human lymphocytes by cathepsin G. (Cell Immunol, 1995 Jan, Abstract available) [MEDLINE]
87 Rakoczy PE, et al; Modulation of cathepsin D activity in retinal pigment epithelial cells. (Biochem J, 1997 Jun, Abstract available) [MEDLINE]
88 Nishinaka T, et al; A unique cathepsin-like protease isolated from CV-1 cells is involved in rapid degradation of retinoblastoma susceptibility gene product, RB, and transcription factor SP1. (Biochim Biophys Acta, 1997 Apr, Abstract available) [MEDLINE]
89 Linnevers C, et al; Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes. (FEBS Lett, 1997 Apr, Abstract available) [MEDLINE]
90

Menu Position #90

van Eijk M, et al; Germinal center B cell apoptosis requires both caspase and cathepsin activity. (J Immunol, 1999 Sep, Abstract available) [MEDLINE]

91 Calore EE, et al; The lysosomal enzymes acid phosphatase and cathepsin D in rats intoxicated with Senna occidentalis seeds. (J Submicrosc Cytol Pathol, 1999 Apr, Abstract available) [MEDLINE]
92 Plebani M, et al; Influence of Helicobacter pylori on tryptase and cathepsin D in peptic ulcer. (Dig Dis Sci, 1995 Nov, Abstract available) [MEDLINE]
93 Adenis A, et al; Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. (Cancer Lett, 1995 Sep, Abstract available) [MEDLINE]
94 Li YP, et al; Characterization of mouse cathepsin K gene, the gene promoter, and the gene expression. (J Bone Miner Res, 1999 Apr, Abstract available) [MEDLINE]
95 Rhoads ML, et al; Developmentally regulated secretion of cathepsin L-like cysteine proteases by Haemonchus contortus. (J Parasitol, 1995 Aug, Abstract available) [MEDLINE]
96 Skubitz KM, et al; Preparation and characterization of monoclonal antibodies to human neutrophil cathepsin G, lactoferrin, eosinophil peroxidase, and eosinophil major basic protein. (J Leukoc Biol, 1989 Aug, Abstract available) [MEDLINE]
97 Papassotiropoulos A, et al; Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease. (Neurosci Lett, 1999 Mar, Abstract available) [MEDLINE]
98 Levy J, et al; Cathepsin D-like activity in neutrophils and monocytes. (Infect Immun, 1989 May, Abstract available) [MEDLINE]
99 Conliffe PR, et al; Cloning and expression of a rat placental cDNA encoding a novel cathepsin L-related protein. (Mol Reprod Dev, 1995 Feb, Abstract available) [MEDLINE]
100

Menu Position #100

Wright WW, et al; Germ cell-Sertoli cell interactions: regulation by germ cells of the stage-specific expression of CP-2/cathepsin L mRNA by Sertoli cells. (Dev Genet, 1995, Abstract available) [MEDLINE]

Information on HealthGate.com is not a substitute for professional medical care or advice but should be used only as an aid in understanding current medical knowledge. A physician should always be consulted for any health problem or medical condition.


  

Record 1 from database: MEDLINE
Return To Top

Title
Plasma cathepsin activity and reticuloendothelial phagocytic function during hemorrhagic shock.
Author
Loegering DJ; Carr FK
Address
 
Source
Circ Shock, 1978, 5:1, 61-71
Abstract
The present study evaluated two forms of hemorrhagic shock in terms of changes in plasma lysosomal enzyme activity, reticuloendothelial system (RES) phagocytic function, and plasma opsonic activity. Hemorrhagic shock was induced in rats by withdrawal of a fixed volume of blood equivalent to 3% body weight or by maintaining the arterial blood pressure at 40--45 mm Hg. Plasma cathepsin activity did not increase until after one hour of hypotension, and was increased 2.7-fold two hours after a 3% body weight hemorrhage and 11-fold after two hours at a blood pressure of 40--45 mm Hg. Phagocytic index and plasma opsonic activity were decreased in animals reinfused at 0, 30, or 120 minutes following a 3% body weight hemorrhage and in animals reinfused 0, 30, and 90 minutes following hemorrhage to a blood pressure of 40 mm Hg. There was a strong temporal relationship between the changes in phagocytic index and plasma opsonic activity; however, the decrease in RES function occurred earlier than the increase in plasma lysosomal enzyme activity. These results suggest that the depression of RES function during shock may be mediated, in part, by a deficit in circulating opsonic activity and that RES depression occurs prior to shock-induced cellular injury during hemorrhagic shock.
Language of Publication
English
Unique Identifier
78167657

Return To Top


MeSH Heading (Major)
Cathepsins|*BL; Phagocytosis|*; Reticuloendothelial System|EN/*PP; Shock, Hemorrhagic|EN/*PP
MeSH Heading
Animal; Blood Pressure; Lysosomes|EN; Male; Opsonins|AN; Phagocytes|EN; Rats; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0092-6213
Country of Publication
UNITED STATES

Record 2 from database: MEDLINE
Return To Top

Title
Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Author
Camire RM; Kalafatis M; Tracy PB
Address
Department of Biochemistry, University of Vermont, College of Medicine, Burlington, Vermont 05405, USA.
Source
Biochemistry, 1998 Aug, 37:34, 11896-906
Abstract
The single-chain procofactor factor V is cleaved by thrombin (FVaIIa) at Arg709, Arg1018, and Arg1545 and by a variety of other proteases to generate a cofactor species with various levels of cofactor function. Having demonstrated previously that monocyte-bound forms of cathepsin G and elastase cleave and activate factor V, studies were initiated here using purified proteins to probe factor V structure/function. Electrophoretic, Western blotting, and amino-terminal sequence analyses revealed that cathepsin G cleaves factor V at several sites (Phe1031, Leu1447, Tyr1518, and potentially Tyr696), ultimately generating an amino-terminal 103 kDa heavy chain and a carboxy-terminal 80 kDa light chain (FVaCG). Elastase also cleaves factor V at several sites (Ile708, Ile819, Ile1484, and potentially Thr678), generating a cofactor species, FVaHNE, with an amino-terminal 102 kDa heavy chain and a carboxy-terminal 90 kDa light chain. Incubation of FVaIIa with either cathepsin G or elastase resulted in cleavage within the heavy chain, releasing peptides of approximately 2000 and approximately 3000 Da, respectively, generating FVaIIa/CG and FVaIIa/HNE. The functional activity of each cofactor species was assessed either by clotting assay or by employing a purified prothrombinase assay using saturating amounts of factor Xa. Significant differences in cofactor function were observed between the two assay systems. Whereas FVaIIa, FVaCG, FVaIIa/CG, FVaHNE, and FVaIIa/HNE all had similar cofactor activities in the purified prothrombinase assay, FVaCG and FVaHNE had no cofactor activity in the clotting-based assay, and FVaIIa/CG and FVaIIa/HNE had approximately 30-35% clotting activity relative to FVaIIa. These disparate results led us to examine the binding interactions of these cofactors with the various prothrombinase components. Kinetic analyses indicated that FVaIIa (Kd(app) = 0.096 nM), FVaIIa/CG (Kd(app) = 0.244 nM), and FVaIIa/HNE (Kd(app) = 0.137 nM) bound to membrane-bound factor Xa much more effectively than FVaCG (Kd(app) = 1.46 nM) and FVaHNE (Kd(app) = 0.818 nM). In contrast, studies of the activated protein C (APC)-catalyzed inactivation of each of the factor V(a) species indicated that they were all equivalent substrates for APC with no differences observed in the rate of inactivation or the cleavage mechanism, suggesting that APC interacts with the light chain at a site distinct from factor Xa. The Km values for prothrombin, as well as the kcat values for each of the FV(a) species, were all similar (approximately 0.25 microM and approximately 1900 min-1). In addition, kinetic analyses indicated that whereas FVaCG and FVaHNE exhibited a slightly reduced ability to interact with phospholipid vesicles (approximately 2-3-fold), the remaining FV(a) species assembled equally well on this surface. Collectively, these data indicate that FVaCG and FVaHNE have a diminished capacity to support factor Xa binding; however, cleavage at Arg1545 and removal of the extended B-domain in these cofactors restore near-total factor Xa binding. Thus, cleavage at Arg1545 optimizes cofactor function within prothrombinase by facilitating factor Xa binding to membrane-bound FVa.
Language of Publication
English
Unique Identifier
98384156

Return To Top


MeSH Heading (Major)
Arginine|*ME; Cathepsins|*ME/PH; Factor V|CH/*ME; Factor Xa|*ME; Pancreatic Elastase|*ME/PH
MeSH Heading
Binding Sites; Blood Coagulation Tests|MT; Catalysis; Enzyme Activation; Factor Va|ME; Human; Hydrolysis; Kinetics; Membranes, Artificial; Phosphatidylcholines|ME; Phosphatidylserines|ME; Protein Binding; Protein C|ME; Prothrombin|ME; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-2960
Country of Publication
UNITED STATES

Record 3 from database: MEDLINE
Return To Top

Title
Human leucocyte elastase and cathepsin G: structural and functional characteristics.
Author
Travis J; Giles PJ; Porcelli L; Reilly CF; Baugh R; Powers J
Address
 
Source
Ciba Found Symp, 1979, :75, 51-68
Abstract
Two of the major enzymes present in an released from neutrophil granulocytes are the endoproteinases elastase and cathepsin G. While the former is believed to be one of the major causative agents responsible for tissue destruction in emphysema and rheumatoid arthritis, little is known about the function of cathepsin G. We have recently developed simple procedures for isolating the isoenzymes of each type of proteinase as well as for their specific controlling plasma inhibitors. We have also prepared synthetic substrates and inhibitor analogues. Some sequence studies have been initiated and the results indicate homology of these enzymes not only with each other and with the pancreatic proteinases but also between cathepsin G and proteolytic enzymes present in muscle and mast cell tissue. Significantly, both types of enzyme can degrade the structural protein myosin, as well as elastin and proteoglycan. However, their relative importance in muscle protein turnover or muscle disease has not yet been clarified.
Language of Publication
English
Unique Identifier
81089733

Return To Top


MeSH Heading (Major)
Cathepsins|*/AI/IP/ME; Leukocytes|*EN; Pancreatic Elastase|*/AI/IP/ME
MeSH Heading
Amino Acid Sequence; Human; Isoenzymes|IP; Molecular Weight; Proteins|ME

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0300-5208
Country of Publication
NETHERLANDS

Record 4 from database: MEDLINE
Return To Top

Title
Proteoglycan-degrading enzymes. A radiochemical assay method and the detection of a new enzyme cathepsin F.
Author
Dingle JT; Blow AM; Barrett AJ; Martin PE
Address
 
Source
Biochem J, 1977 Dec, 167:3, 775-85
Abstract
1. Polyacrylamide beads containing entrapped 35S-labelled proteoglycan molecules have been prepared. 2. The measurement of release of radioactivity provides an extremely sensitive assay for proteoglycan-degrading enzymes, including proteinases and hyaluronidase. 3. The amount of label released is a logarithmic function of enzyme concentration or time of incubation. Experiments were made in an attempt to explain this. 4. Assays were made by the new method at several pH values, and with the inclusion of inhibitors to identify the proteoglycan-degrading enzymes of rabbit ear cartilage. 5. A previously undescribed proteinase active against proteoglycan at pH4.5 but unaffected by pepstatin, was discovered. The enzyme was named cathepsin F, and was partially purified and characterized; it was detected in human articular cartilage.
Language of Publication
English
Unique Identifier
78103158

Return To Top


MeSH Heading (Major)
Cathepsins|AI/*AN/IP; Proteoglycans|*
MeSH Heading
Acrylamides; Animal; Cartilage|EN; Chromatography, Gel; Human; Hydrogen-Ion Concentration; IgG; Pepstatins|PD; Rabbits; Sepharose; Subcellular Fractions|EN; Sulfur Radioisotopes; Viscosity

Publication Type
JOURNAL ARTICLE
ISSN
0006-2936
Country of Publication
ENGLAND

Record 5 from database: MEDLINE
Return To Top

Title
Cathepsin D: ultra-immunohistochemical localization in dentinogenesis.
Author
Nygren H; Persliden B; Hansson HA; Linde A
Address
 
Source
Calcif Tissue Int, 1979, 29:3, 251-6
Abstract
Cathepsin D was purified from rat liver using a new affinity chromatographic method, based on the coupling to the specific inhibitor pepstatin. This preparation was used for the production of specific antibodies from rabbit. The purified IgG fraction was conjugated to horseradish peroxidase in a two-step coupling procedure and used for electron microscopic immunohistochemistry of the odontoblast-predentine region of the rat incisor. Precipitates, indicating the presence of cathepsin D, were seen in the odontoblast, odontoblast process, and in the extracellular unmineralized matrix, the predentine. The observations are discussed in relation to proteoglycan degradation at the mineralization front simultaneous with crystal formation, and in relation to the function of lysosomal enzymes in the turnover of connective tissue.
Language of Publication
English
Unique Identifier
80089530

Return To Top


MeSH Heading (Major)
Cathepsins|*AN/IP; Dentinogenesis|*; Incisor|*EN/UL; Odontoblasts|*EN/UL
MeSH Heading
Animal; Chromatography, Affinity; Immunoenzyme Techniques; Liver|EN; Rats

Publication Type
JOURNAL ARTICLE
ISSN
0171-967X
Country of Publication
UNITED STATES

Record 6 from database: MEDLINE
Return To Top

Title
Inhibition of human liver cathepsin L by alpha 2 cysteine-proteinase inhibitor and the low-Mr cysteine proteinase inhibitor from human serum.
Author
Pagano M; Esnard F; Engler R; Gauthier F
Address
 
Source
Biochem J, 1984 May, 220:1, 147-55
Abstract
The inhibition of human liver cathepsin L by two specific proteinase inhibitors present in human serum, namely alpha 2 cysteine-proteinase inhibitor and the low-Mr cysteine-proteinase inhibitor, was studied. Kinetic parameters, including inhibition constants (Ki) and rate constants for association and dissociation (k+1 and K-1), were determined. The values found are consistent with a possible physiological function of these inhibitors to control cathepsin L activity. Furthermore, a transfer of active proteinase from the complex with either cysteine-proteinase inhibitor species to alpha 2-macroglobulin was demonstrated in vitro. Given the rate of dissociation of both cathepsin-L-cysteine-proteinase inhibitor complexes, a function of transitory inhibitor can therefore be hypothesized for these proteins and might then provide an explanation of the clearance of lysosomal proteinases.
Language of Publication
English
Unique Identifier
84256619

Return To Top


MeSH Heading (Major)
Cathepsins|*AI; Liver|*EN; Protease Inhibitors|*PD; Sulfhydryl Compounds|BL/IP/*PD
MeSH Heading
Binding Sites; Human; Kinetics; Lysosomes|EN; Macromolecular Systems

Publication Type
JOURNAL ARTICLE
ISSN
0264-6021
Country of Publication
ENGLAND

Record 7 from database: MEDLINE
Return To Top

Title
Cathepsin B from human renal cortex.
Author
Gounaris AD; Slater EE
Address
 
Source
Biochem J, 1982 Aug, 205:2, 295-302
Abstract
Cysteine-proteinase activity was observed in homogenates of human-cadaver renal cortex. This activity co-purified with renin enzymic activity until separation by aminohexyl-Sepharose--pepstatin affinity chromatography. The cysteine proteinase was purified 1780-fold after the following successive chromatographic procedures: Sephadex G-75, DEAE-cellulose DE-52, and an organomercurial affinity resin. The proteinase activity was dependent upon activation by thiol-containing compounds such as dithiothreitol, as well as by EDTA, and was inhibited by the thiol-group-specific alkylating reagents iodoacetic acid and N-ethylmaleimide. DE-52 cellulose chromatography resolved the cysteine proteinase into two components. On the basis of molecular size (26 000 daltons), activity as a function of pH, stability as a function of pH, substrate specificity and thermal lability, the major component (95%) has been identified as cathepsin B. The DE-52 cellulose elution pattern of the minor component (5%) is suggestive of cathepsin H [Schwartz & Barrett (1980) Biochem. J. 191, 487-497] Enzymic activity was determined with synthetic substrates, in particular alpha-N-benzoyl-DL-arginine 2-naphthylamide (Bz-Arg-NNap), thus precluding the detection of cathepsin L [Kirschke, Langner, Wiederanders, Ansorge, Bohley & Broghammer (1976) Acta Biol. Med. Germ. 35, 285-299]. Inhibition by dimethyl sulphoxide was observed in the determination of Km = 7.0 +/- 0.4 mM for the substrate Bz-Arg-NNap, and care must therefore be taken in the preparation of substrate solutions.
Language of Publication
English
Unique Identifier
83048214

Return To Top


MeSH Heading (Major)
Cathepsins|AI/*IP/*ME; Kidney Cortex|*EN
MeSH Heading
Chromatography, Affinity; Chromatography, Gel; Chromatography, Ion Exchange; Dimethyl Sulfoxide|PD; Electrophoresis, Polyacrylamide Gel; Human; Substrate Specificity; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-2936
Country of Publication
ENGLAND

Record 8 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Specificity and some physical properties of cathepsin D from bovine uterus and dental pulp.
Author
Schwabe C
Address
 
Source
J Dent Res, 1975 Mar, 54:2, 371-7
Abstract
The action of uterine cathepsin D on the insulin A-chain (S-sulfo) and porcine glucagon was compared with the action of bovine dental pulp cathepsin on the same substrates. Differences observed with respect to molecular and catalytic properties suggest that different gene products (coding for the same function) are used during cell differentiation.
Language of Publication
English
Unique Identifier
75115257

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Cathepsins|*/AN/PD; Dental Pulp|*EN; Uterus|*EN
MeSH Heading
Amino Acids|AN; Animal; Carbohydrates|AN; Cattle; Chemistry; Chlorides|PD; Chromatography; Dithiothreitol|PD; Electrophoresis, Polyacrylamide Gel; Endonucleases|ME; Female; Glucagon|ME; Insulin|ME; Iron|PD; Molecular Weight; Peptide Fragments|AN/ME; Ribonucleases|ME; Support, U.S. Gov't, P.H.S.; Swine

Publication Type
JOURNAL ARTICLE
ISSN
0022-0345
Country of Publication
UNITED STATES

Record 9 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
SPI-1-dependent host range of rabbitpox virus and complex formation with cathepsin G is associated with serpin motifs.
Author
Moon KB; Turner PC; Moyer RW
Address
Department of Molecular Genetics, University of Florida, Gainesville, Florida 32610-0266, USA.
Source
J Virol, 1999 Nov, 73:11, 8999-9010
Abstract
Serpins are a superfamily of serine proteinase inhibitors which function to regulate a number of key biological processes including fibrinolysis, inflammation, and cell migration. Poxviruses are the only viruses known to encode functional serpins. While some poxvirus serpins regulate inflammation (myxoma virus SERP1 and cowpox virus [CPV] crmA/SPI-2) or apoptosis (myxoma virus SERP2 and CPV crmA/SPI-2), the function of other poxvirus serpins remains unknown. The rabbitpox virus (RPV) SPI-1 protein is 47% identical to crmA and shares all of the serpin structural motifs. However, no serpin-like activity has been demonstrated for SPI-1 to date. Earlier we showed that RPV with the SPI-1 gene deleted, unlike wild-type virus, fails to grow on A549 or PK15 cells (A. Ali, P. C. Turner, M. A. Brooks, and R. W. Moyer, Virology 202:306-314, 1994). Here we demonstrate that in the absence of a functional SPI-1 protein, infected nonpermissive cells which exhibit the morphological features of apoptosis fail to activate terminal caspases or cleave the death substrates PARP or lamin A. We show that SPI-1 forms a stable complex in vitro with cathepsin G, a member of the chymotrypsin family of serine proteinases, consistent with serpin activity. SPI-1 reactive-site loop (RSL) mutations of the critical P1 and P14 residues abolish this activity. Viruses containing the SPI-1 RSL P1 or P14 mutations also fail to grow on A549 or PK15 cells. These results suggest that the full virus host range depends on the serpin activity of SPI-1 and that in restrictive cells SPI-1 inhibits a proteinase with chymotrypsin-like activity and may function to inhibit a caspase-independent pathway of apoptosis.
Language of Publication
English
Unique Identifier
99445805

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Cathepsins|*ME; Peptides|CH/GE/*ME; Serine Proteinase Inhibitors|CH/GE/*ME; Serpins|CH/GE/*ME; Vaccinia Virus|GD/GE/*ME/*PY
MeSH Heading
Amino Acid Motifs; Amino Acid Sequence; Caspases|ME; Cell Line; Chymotrypsin|AI/ME; Human; Molecular Sequence Data; Mutagenesis, Site-Directed; Serine Endopeptidases|ME; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0022-538X
Country of Publication
UNITED STATES

Record 10 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
SPI-1-dependent host range of rabbitpox virus and complex formation with cathepsin G is associated with serpin motifs.
Author
Moon KB; Turner PC; Moyer RW
Address
Department of Molecular Genetics, University of Florida, Gainesville, Florida 32610-0266, USA.
Source
J Virol, 1999 Nov, 73:11, 8999-9010
Abstract
Serpins are a superfamily of serine proteinase inhibitors which function to regulate a number of key biological processes including fibrinolysis, inflammation, and cell migration. Poxviruses are the only viruses known to encode functional serpins. While some poxvirus serpins regulate inflammation (myxoma virus SERP1 and cowpox virus [CPV] crmA/SPI-2) or apoptosis (myxoma virus SERP2 and CPV crmA/SPI-2), the function of other poxvirus serpins remains unknown. The rabbitpox virus (RPV) SPI-1 protein is 47% identical to crmA and shares all of the serpin structural motifs. However, no serpin-like activity has been demonstrated for SPI-1 to date. Earlier we showed that RPV with the SPI-1 gene deleted, unlike wild-type virus, fails to grow on A549 or PK15 cells (A. Ali, P. C. Turner, M. A. Brooks, and R. W. Moyer, Virology 202:306-314, 1994). Here we demonstrate that in the absence of a functional SPI-1 protein, infected nonpermissive cells which exhibit the morphological features of apoptosis fail to activate terminal caspases or cleave the death substrates PARP or lamin A. We show that SPI-1 forms a stable complex in vitro with cathepsin G, a member of the chymotrypsin family of serine proteinases, consistent with serpin activity. SPI-1 reactive-site loop (RSL) mutations of the critical P1 and P14 residues abolish this activity. Viruses containing the SPI-1 RSL P1 or P14 mutations also fail to grow on A549 or PK15 cells. These results suggest that the full virus host range depends on the serpin activity of SPI-1 and that in restrictive cells SPI-1 inhibits a proteinase with chymotrypsin-like activity and may function to inhibit a caspase-independent pathway of apoptosis.
Language of Publication
English
Unique Identifier
99445805

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Cathepsins|*ME; Peptides|CH/GE/*ME; Serine Proteinase Inhibitors|CH/GE/*ME; Serpins|CH/GE/*ME; Vaccinia Virus|GD/GE/*ME/*PY
MeSH Heading
Amino Acid Motifs; Amino Acid Sequence; Caspases|ME; Cell Line; Chymotrypsin|AI/ME; Human; Molecular Sequence Data; Mutagenesis, Site-Directed; Serine Endopeptidases|ME; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0022-538X
Country of Publication
UNITED STATES

Record 11 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function.
Author
Galjart NJ; Morreau H; Willemsen R; Gillemans N; Bonten EJ; dAzzo A
Address
Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands.
Source
J Biol Chem, 1991 Aug, 266:22, 14754-62
Abstract
The protective protein was first discovered because of its deficiency in the metabolic storage disorder galactosialidosis. It associates with lysosomal beta-galactosidase and neuraminidase, toward which it exerts a protective function necessary for their stability and activity. Human and mouse protective proteins are homologous to yeast and plant serine carboxypeptidases. Here, we provide evidence that this protein has enzymatic activity similar to that of lysosomal cathepsin A: 1) overexpression of human and mouse protective proteins in COS-1 cells induces a 3-4-fold increase of cathepsin A-like activity; 2) this activity is reduced to approximately 1% in three galactosialidosis patients with different clinical phenotypes; 3) monospecific antibodies raised against human protective protein precipitate virtually all cathepsin A-like activity in normal human fibroblast extracts. Mutagenesis of the serine and histidine active site residues abolishes the enzymatic activity of the respective mutant protective proteins. These mutants, however, behave as the wild-type protein with regard to intracellular routing, processing, and secretion. In contrast, modification of the very conserved Cys60 residue interferes with the correct folding of the precursor polypeptide and, hence, its intracellular transport and processing. The secreted active site mutant precursors, endocytosed by galactosialidosis fibroblasts, restore beta-galactosidase and neuraminidase activities as effectively as wild-type protective protein. These findings indicate that the catalytic activity and protective function of the protective protein are distinct.
Language of Publication
English
Unique Identifier
91317848

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
beta-Galactosidase|*ME; Carboxypeptidases|*ME; Cathepsins|*ME; Glycoproteins|*ME; Lysosomes|EN/*ME
MeSH Heading
Amino Acid Sequence; Animal; Cell Line; Chickens; Fluorescent Antibody Technique; Human; Immunohistochemistry; Mice; Microscopy, Immunoelectron; Molecular Sequence Data; Mutagenesis, Site-Directed; Neuraminidase|ME; Sequence Alignment; Transfection

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES

Record 12 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Expression of rat cathepsin D cDNA in Saccharomyces cerevisiae: implications for intracellular targeting of cathepsin D to vacuoles.
Author
Nishimura Y; Takeshima H; Sakaguchi M; Mihara K; Omura T; Kato K; Himeno M
Address
Division of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka.
Source
J Biochem (Tokyo), 1995 Jul, 118:1, 168-77
Abstract
To investigate the intracellular transport mechanisms of lysosomal cathepsin D in yeast cells, we produced cathepsin D in Saccharomyces cerevisiae by placing the coding region under the control of the promoter of the yeast glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene. Immunoblotting analysis by the use of an antibody specific for rat cathepsin D coding sequence produced an intermediate species which had a slightly higher molecular weight than that of the mature cathepsin D. Cell fractionation experiments demonstrated that the cathepsin D polypeptide was colocalized to the yeast vacuoles with the marker enzyme carboxypeptidase Y in a Ficoll step gradient. A biosynthesis study with pulse-chase kinetic analysis revealed that the precursor polypeptide was accurately sorted to the yeast vacuoles as determined by cell fractionation, and that N-linked carbohydrate modifications were not required for vacuolar sorting of this protein. To elucidate the role of the propeptide region of cathepsin D, which might function in the intracellular targeting to the vacuole, a deletion mutant of cathepsin D lacking the propeptide was prepared and its intracellular targeting was examined after transfection into yeast cells. Immunoblotting analysis demonstrated that the propeptide-deleted mutant protein was recovered in a low quantity as compared with that in the case of yeast cells expressing the wild-type protein in the isolated vacuolar fraction. Immunofluorescence analysis revealed that the deletion mutant protein appeared to be accumulated within the intracellular small vesicles but not in the carboxypeptidase Y-positive vacuoles. Overall, these results indicate that the rat cathepsin D precursor polypeptide is recognized by mechanisms similar to those involved in the intracellular sorting of vacuolar proteins through the ER/Golgi/vacuolar sorting pathway in yeast cells, and that the propeptide has an important function in translocation of the cathepsin D polypeptide to the vacuole.
Language of Publication
English
Unique Identifier
96015165

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Cathepsin D|BI/*GE; DNA, Complementary|*BI; Promoter Regions (Genetics)|*; Vacuoles|*DE/GE
MeSH Heading
Animal; Biological Transport; Fluorescent Antibody Technique, Indirect; Gene Deletion; Glycosylation; Mutation; Rats; Recombinant Proteins|BI; Saccharomyces cerevisiae; Support, Non-U.S. Gov't; Tunicamycin|PD

Publication Type
JOURNAL ARTICLE
ISSN
0021-924X
Country of Publication
JAPAN

Record 13 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation.
Author
Afonso S; Romagnano L; Babiarz B
Address
Department of Cell, Developmental and Neurobiology, Nelson Labs, Busch Campus, Rutgers University, Piscataway, NJ 08855, USA. afonso@rci.rutgers.edu
Source
Development, 1997 Sep, 124:17, 3415-25
Abstract
The implantation of the mouse embryo requires the controlled invasion of the uterine stroma by the embryonic trophoblast. This event is dependent, in part, on the secretion of matrix metalloproteinases and serine proteinases for the extracellular degradation of the uterine matrix. Proteinase activity is controlled by stromal decidualization and specific proteinase inhibitors. This work adds to our understanding of implantation and placentation by reporting the expression and function of another class of proteinases/inhibitors closely related to invasive cell behavior. We focused on the cysteine proteinases, cathepsins B and L, and their inhibitor cystatin C. Northern blots showed that trophoblast expressed cathepsin B throughout the invasive period (days 5.5-10.5). Both cathepsin B message and cathepsin L protein were localized to the mature, invasive trophoblast giant cells. Substrate gel electrophoresis showed an increase in giant cell cathepsin activity with enzyme profiles changing at the end of the invasive period. Northern and western blotting showed that cystatin C, the main inhibitor of cathepsins, was a major product of the decidualizing stroma. Message levels first increased in peripheral decidualizing cells, with the protein localizing close to the embryo during implantation (days 5.5-8.5). With the regression of the decidua beginning on day 9.5, a coordinated upregulation of both cathepsin B and cystatin C was observed implying a role for controlled cathepsin expression during apoptosis. E-64, a synthetic inhibitor of cathepsins B and L, was injected into pregnant females at the stage of blastocyst attachment (days 4.5-5.5). High doses resulted in the complete failure of implantation while lower doses resulted in stunted embryos and a reduced decidual reaction. These results suggested that cathepsins B and L are necessary for normal embryo development and uterine decidualization, and that decidua contributes to their control by a coordinated expression of cystatin C within the implantation site.
Language of Publication
English
Unique Identifier
97454261

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Cathepsin B|AI/*GE/*PH; Cathepsins|AI/*GE/*PH; Cystatins|*GE/*PH; Ovum Implantation|DE/*GE/*PH; Placentation|DE/*GE/*PH
MeSH Heading
Animal; Cysteine Proteinase Inhibitors|PD; Decidua|ME; Female; Gene Expression; In Situ Hybridization; Leucine|AA/PD; Male; Mice; Pregnancy; RNA, Messenger|GE/ME; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Trophoblast|ME

Publication Type
JOURNAL ARTICLE
ISSN
0950-1991
Country of Publication
ENGLAND

Record 14 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Comparative effects of cathepsin inhibitors on rat embryonic development in vitro. Evidence that cathepsin D is unimportant in the proteolytic function of yolk sac.
Author
Freeman SJ; Brown NA
Address
 
Source
J Embryol Exp Morphol, 1985 Apr, 86:, 271-81
Abstract
The effects of two proteinase inhibitors, leupeptin and pepstatin on the development of 9.5-day rat conceptuses in vitro has been studied. All cultures were of 48 h duration and the inhibitors were present throughout the entire period. When pepstatin was added to the culture medium (5-25 micrograms/ml) conceptuses developed and grew to an extent that did not differ from untreated controls. However, leupeptin (1-4 micrograms/ml) caused severe growth retardation and abnormal development of conceptuses. The effects of the two inhibitors on the hydrolysis of 125I-labelled BSA and haemoglobin by homogenates of 10.5-day yolk sac indicated the biochemical basis for the differential toxic effects of the two inhibitors on development. Leupeptin was highly inhibitory of the degration of both substrates whereas pepstatin caused no inhibition of 125I-labelled BSA hydrolysis, and only a slight inhibition of haemoglobin hydrolysis. These observations demonstrate that cathepsin D, a lysosomal aspartic proteinase that is specifically inhibited by pepstatin is not involved in yolk-sac-mediated protein utilization by early organogenesis-phase conceptuses and that lysosomal cysteine proteinases, specifically inhibited by leupeptin, are of paramount importance in this yolk sac function.
Language of Publication
English
Unique Identifier
85291486

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Cathepsins|*AI; Fetal Development|*DE; Yolk Sac|*ME
MeSH Heading
Animal; Cathepsin D|ME; Cells, Cultured; Comparative Study; Hemoglobins|ME; Hydrogen-Ion Concentration; Leupeptins|PD; Pepstatins|PD; Rats; Rats, Inbred Strains; Serum Albumin, Bovine|ME; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0022-0752
Country of Publication
ENGLAND

Record 15 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Immunocytochemical studies of cathepsin D in human skeletal muscle.
Author
Whitaker JN; Bertorini TE; Mendell JR
Address
 
Source
Ann Neurol, 1983 Feb, 13:2, 133-42
Abstract
The distribution of cathepsin D, an acidic endopeptidase, was localized by immunocytochemistry in human skeletal muscle obtained from 34 persons with a variety of neuromuscular disorders. Normal human skeletal muscle contained small amounts of cathepsin D, all of which was found close to the sarcolemmal membrane. Immunoreactive cathepsin D was present in the cytoplasm of many infiltrating phagocytic cells and was increased in skeletal muscle fibers from patients with muscular dystrophies, inflammatory myopathies, rhabdomyolysis, acid maltase deficiency, and neurogenic atrophy. In cases of Duchenne type muscular dystrophy, the increase in cathepsin D was especially prominent in small regenerating fibers, in which it was visualized at the ultrastructural level in lysosome-like organelles and extralysosomal locations. The function of cathepsin D in skeletal muscle is unclear, but the present findings suggest a possible role in muscle regeneration and repair. Such a role would necessitate careful selection of drugs which interfere with proteolytic activity if they are to be used as therapeutic agents in treating neuromuscular diseases.
Language of Publication
English
Unique Identifier
83151354

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Cathepsins|*IM; Immunologic Techniques|*; Muscles|*AN/UL
MeSH Heading
Adolescence; Antibodies|AN; Child; Histocytochemistry; Human; Male; Muscular Diseases|ME/PA; Muscular Dystrophies|ME; Neuromuscular Diseases|ME; Support, U.S. Gov't, Non-P.H.S.; Tissue Distribution

Publication Type
JOURNAL ARTICLE
Country of Publication
UNITED STATES

Record 16 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Changes in sciatic nerve cathepsin D after ligation or exposure to neurotoxins.
Author
Whitaker JN; Dodd SP; Sahenk Z; Mendell JR
Address
 
Source
J Neuropathol Exp Neurol, 1983 Jan, 42:1, 87-98
Abstract
The content and distribution of cathepsin D, a lysosomal acidic endopeptidase, were determined by immunochemical methods in rat sciatic nerve near the site of a ligature or after exposure of animals to neurotoxins. In normal sciatic nerve, cathepsin D was localized predominantly in the perinuclear regions of Schwann cells. In ligated nerve, cathepsin D increased equally in both the proximal and distal nerve segments adjacent to the ligature. Although orthograde and retrograde axonal transport of cathepsin D may have contributed to this increase, immunocytochemical methods indicated that Schwann cells or other phagocytic cells accounted for the bulk of the increased cathepsin D content of nerve. Axonal function was nontraumatically altered by the administration of 2,5-hexanedione, acrylamide, B,B'-iminodipropionitrile or zinc pyridinethione. Exposure to any of these neurotoxins raised cathepsin D content throughout the sciatic nerve twofold or more, and greater amounts of immunoreactive cathepsin D in the cytoplasm of Schwann cells could be demonstrated immunocytochemically. These results indicate that changes in cathepsin D content of Schwann cells may be a reflection of their catabolic activity. The increased Schwann cell cathepsin D content in toxic axonopathies is further proof for an enhanced Schwann cell role as a phagocyte resulting from axonal injury.
Language of Publication
English
Unique Identifier
83111068

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Cathepsins|*AN/PH; Sciatic Nerve|*AN/DE/PH/UL
MeSH Heading
Animal; Axonal Transport|DE; Ligation; Male; Neurotoxins|PD; Rats; Rats, Inbred Strains; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0022-3069
Country of Publication
UNITED STATES

Record 17 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
Author
Kinlough Rathbone RL; Perry DW; Rand ML; Packham MA
Address
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Source
Thromb Res, 1999 Sep, 95:6, 315-23
Abstract
Cathepsin G, a proteolytic enzyme from activated leukocytes, can interact with platelets during inflammation and thrombosis. Platelets that have been exposed to cathepsin G in thrombi may recirculate if they are freed during fibrinolysis. To determine whether some of the subsequent functions of such platelets would be impaired, we investigated the responses of cathepsin G-pretreated platelets to agonists that they would encounter in the circulation. Suspensions of washed human platelets were labeled with [14C]serotonin and resuspended in Tyrode-albumin solution (with 2 mM Ca2+ and apyrase). After 15 minute incubation with 400 nM cathepsin G at 37 degrees C, 52+/-3% of [14C]serotonin had been released, and glycoprotein Ib was degraded. The platelets were washed and resuspended in fresh medium to remove cathepsin G and released materials. Ristocetin-induced agglutination was abolished, indicating that the binding site for von Willebrand Factor on glycoprotein Ib had been removed. Aggregation and release of residual [14C]serotonin in response to 0.1-1.0 U/mL thrombin was blocked or greatly reduced by the cathepsin G pretreatment. This inhibition is probably largely due to cleavage by cathepsin G of some of the protease-activated receptors at the C-terminal side of Ser42 so that the tethered ligand is lost. Pretreatment with cathepsin G did not affect responses to ADP or a low concentration of platelet-activating factor in the presence of fibrinogen, indicating that receptors for these agonists were unaffected and that the function of the fibrinogen receptor, GPIIb/IIIa was unchanged. Responses to cathepsin G, the thrombin receptor-activating peptide SFLLRN, collagen, or the thromboxane A2 mimetic U46619 were partially inhibited, even in the presence of added fibrinogen. Platelet adhesion to a collagen-coated surface was 51+/-7% inhibited, which may indicate cleavage of a collagen receptor or receptors; this may partly account for strong inhibition of collagen-induced aggregation and release of granule contents; additionally, as shown by inhibition of responses to U46619, the function of the thromboxane A2 receptor may be compromised. Thus, although cathepsin G activates platelets, if they recirculate after interaction with it, their subsequent adhesion to damaged vessel walls, aggregation, and release of granule contents induced by thrombin and collagen will be diminished.
Language of Publication
English
Unique Identifier
99454533

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Antibiotics, Peptide|*PD; Cathepsins|*PD; Platelet Aggregation|*DE; Ristocetin|*PD
MeSH Heading
Adenosine Diphosphate|PD; Blood Platelets|ME/PA; Drug Interactions; Hemostatics|PD; Human; Platelet Activating Factor|PD; Platelet Glycoprotein GPIb-IX Complex|ME; Serotonin|ME; Support, Non-U.S. Gov't; Thrombin|PD; Vasoconstrictor Agents|PD; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid|PD

Publication Type
JOURNAL ARTICLE
ISSN
0049-3848
Country of Publication
UNITED STATES

Record 18 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
Author
Kinlough Rathbone RL; Perry DW; Rand ML; Packham MA
Address
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Source
Thromb Res, 1999 Sep, 95:6, 315-23
Abstract
Cathepsin G, a proteolytic enzyme from activated leukocytes, can interact with platelets during inflammation and thrombosis. Platelets that have been exposed to cathepsin G in thrombi may recirculate if they are freed during fibrinolysis. To determine whether some of the subsequent functions of such platelets would be impaired, we investigated the responses of cathepsin G-pretreated platelets to agonists that they would encounter in the circulation. Suspensions of washed human platelets were labeled with [14C]serotonin and resuspended in Tyrode-albumin solution (with 2 mM Ca2+ and apyrase). After 15 minute incubation with 400 nM cathepsin G at 37 degrees C, 52+/-3% of [14C]serotonin had been released, and glycoprotein Ib was degraded. The platelets were washed and resuspended in fresh medium to remove cathepsin G and released materials. Ristocetin-induced agglutination was abolished, indicating that the binding site for von Willebrand Factor on glycoprotein Ib had been removed. Aggregation and release of residual [14C]serotonin in response to 0.1-1.0 U/mL thrombin was blocked or greatly reduced by the cathepsin G pretreatment. This inhibition is probably largely due to cleavage by cathepsin G of some of the protease-activated receptors at the C-terminal side of Ser42 so that the tethered ligand is lost. Pretreatment with cathepsin G did not affect responses to ADP or a low concentration of platelet-activating factor in the presence of fibrinogen, indicating that receptors for these agonists were unaffected and that the function of the fibrinogen receptor, GPIIb/IIIa was unchanged. Responses to cathepsin G, the thrombin receptor-activating peptide SFLLRN, collagen, or the thromboxane A2 mimetic U46619 were partially inhibited, even in the presence of added fibrinogen. Platelet adhesion to a collagen-coated surface was 51+/-7% inhibited, which may indicate cleavage of a collagen receptor or receptors; this may partly account for strong inhibition of collagen-induced aggregation and release of granule contents; additionally, as shown by inhibition of responses to U46619, the function of the thromboxane A2 receptor may be compromised. Thus, although cathepsin G activates platelets, if they recirculate after interaction with it, their subsequent adhesion to damaged vessel walls, aggregation, and release of granule contents induced by thrombin and collagen will be diminished.
Language of Publication
English
Unique Identifier
99454533

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Antibiotics, Peptide|*PD; Cathepsins|*PD; Platelet Aggregation|*DE; Ristocetin|*PD
MeSH Heading
Adenosine Diphosphate|PD; Blood Platelets|ME/PA; Drug Interactions; Hemostatics|PD; Human; Platelet Activating Factor|PD; Platelet Glycoprotein GPIb-IX Complex|ME; Serotonin|ME; Support, Non-U.S. Gov't; Thrombin|PD; Vasoconstrictor Agents|PD; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid|PD

Publication Type
JOURNAL ARTICLE
ISSN
0049-3848
Country of Publication
UNITED STATES

Record 19 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Effects of cell density and cell proliferation on acid cholesterol esterase and cathepsin activity of cultured human skin fibroblasts.
Author
Kenagy RD; Bierman EL
Address
 
Source
Biochim Biophys Acta, 1983 Nov, 754:2, 174-80
Abstract
We tested the effects of fibroblast cell density and proliferation on the activities of acid cholesterol esterase and cathepsins, the lysosomal enzymes which degrade low-density lipoprotein. Rates of cell proliferation were increased by: (1) fibroblast conditioned medium, (2) increasing the time since subculture from 3 to 7 days, and (3) decreasing the plating density of cells. Cathepsin activity was consistently decreased as cellular proliferation was increased by these various methods. Changes in acid cholesterol esterase activity were more variable. For example, acid cholesterol esterase activity was consistently a positive function of cell density only at densities under 3 micrograms protein/cm2, while cathepsin activity increased up to densities of 16 micrograms protein/cm2. However, the activities of both enzymes were lower at cell densities of under 3 micrograms cell protein/cm2 compared to confluent cultures. Sparse fibroblast cultures may provide a unique model system to study low-density lipoprotein metabolism since, at low cell density, LDL receptor activity is high while lysosomal activity is low, making it possible that lysosomal degradation could become the rate-limiting step in the process of LDL degradation rather than receptor-mediated internalization of the lipoprotein. This might then allow an accumulation of lipoprotein-derived cholesteryl esters in the cell. Such a model could be relevant to the propensity of arterial cells to become foam cells during atherogenesis.
Language of Publication
English
Unique Identifier
84080495

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Carboxylic Ester Hydrolases|*ME; Cathepsins|*ME; Cholesterol Esterase|*ME; Receptors, Cell Surface|*PD; Skin|*EN
MeSH Heading
Cell Count; Cell Division; Cells, Cultured; Fibroblasts|EN; Human; Hydrogen-Ion Concentration; Lipoproteins, LDL|ME; Lysosomes|EN; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-3002
Country of Publication
NETHERLANDS

Record 20 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Identification and characterization of the Cydia pomonella granulovirus cathepsin and chitinase genes.
Author
Kang W; Tristem M; Maeda S; Crook NE; OReilly DR
Address
Department of Biology, Imperial College of Science, Technology and Medicine, London, UK.
Source
J Gen Virol, 1998 Sep, 79 ( Pt 9):, 2283-92
Abstract
A 3.2 kb BamHI-EcoRI fragment of the Cydia pomonella granulovirus (CpGV) genome was subcloned and characterized. Sequence analysis revealed two complete and one partial open reading frames (ORFs). ORF7L is predicted to encode a 66.7 kDa protein (594 amino acid residues) that is 57% identical (amino acid sequence) to the chiA gene (ORF126) of Autographa californica nucleopolyhedrovirus (AcMNPV), encoding a chitinase. ORF8R is 333 amino acids in length and shows high similarity (between 64% and 67%) with baculovirus cathepsins. The partial ORF, ORF5L, is related to AcMNPV ORF145 of unknown function. Phylogenetic trees were constructed for both chitinase and cathepsin sequences from baculoviruses and other species. In both cases, the baculovirus sequences were monophyletic but with a deep division between the GVs and NPVs, suggesting both genes were present in an ancestral virus prior to the separation of the two genera. However, these studies did not provide definitive evidence for the origin of either protein in baculoviruses. To investigate CpGV cathepsin function, a rescue experiment was performed using a Bombyx mori NPV (BmNPV) mutant (BmCysPD) which lacks a functional cathepsin (cath) gene. Larvae infected with BmCysPD-Cp.cat, a BmCysPD derivative carrying CpGV cath, showed similar symptoms to wild-type BmNPV infected insects, confirming that CpGV cath encodes a functional cathepsin. Primer extension analysis of mRNA from BmCysPD-Cp.cat infected cells showed that CpGV cath transcription was initiated from a consensus late transcription motif (ATAAG) within the CpGV sequences, indicating that a CpGV late promoter motif was recognized in this NPV system.
Language of Publication
English
Unique Identifier
98418511

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Baculoviridae|*EN/*GE/PY; Cathepsins|*GE; Chitinase|*GE; Genes, Viral|*; Moths|*VI
MeSH Heading
Amino Acid Sequence; Animal; Base Sequence; Cell Line; Cysteine Endopeptidases|GE; DNA, Viral|GE; Larva|VI; Molecular Sequence Data; Open Reading Frames; Phylogeny; Recombination, Genetic; Restriction Mapping; Sequence Homology, Amino Acid; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0022-1317
Country of Publication
ENGLAND

Record 21 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Effects of human neutrophil elastase and cathepsin G on the reactivity of platelets with antiplatelet antibodies.
Author
Bykowska K; Maslanka K; Uhrynowska M; Kopec M; Lopaciuk S
Address
Laboratory or Blood Coagulation and Hemostasis, Institute of Hematology and Blood Transfusion, Warsaw.
Source
Acta Haematol Pol, 1995, 26:2, 163-70
Abstract
Two human neutrophil serine proteases, elastase (HNE) and cathepsin G (CathG), are known to change the structure and hemostatic function of platelet surface membrane. The platelet membrane contains glycoproteins (GPs) which function as alloantigens, autoantigens and targets of drug-induced antibodies. The aim of this study was to investigate whether proteolysis of platelet GPs by HNE and CathG is associated with changes in the reactivity of platelets to antiplatelet antibodies. The platelet immunoreactivity was examined using the MAIPA (monoclonal antibody-specific immobilization of platelet antigens) assay and PSIFT (platelet suspension immunofluorescence test). The treatment of platelets with HNE led to a moderate increase in their reactivity to quinidine-dependent (anti-GP Ib) antibody and to a slight decline in the expression of HPA-1a. In contrast, CathG did not provoke any significant changes in platelet reactions with quinidine dependent and anti-HPA-1a antibodies. Both enzymes had no significant effect on the expression of HLA-A2, HLA-A3, HLA-B7 and HLA-B8 on platelets.
Language of Publication
English
Unique Identifier
95381743

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Antibodies|*IM; Blood Platelets|*IM; Cathepsins|*ME; Pancreatopeptidase|*ME; Platelet Membrane Glycoproteins|*ME; Serine Proteinases|*ME
MeSH Heading
Fluorescent Antibody Technique; Human; Immunoblotting; In Vitro

Publication Type
JOURNAL ARTICLE
ISSN
0001-5814
Country of Publication
POLAND

Record 22 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
The atomic model of the human protective protein/cathepsin A suggests a structural basis for galactosialidosis.
Author
Rudenko G; Bonten E; Hol WG; dAzzo A
Address
Department of Biological Structure, Howard Hughes Medical Institute, University of Washington, Seattle 98195-7742, USA.
Source
Proc Natl Acad Sci U S A, 1998 Jan, 95:2, 621-5
Abstract
Human protective protein/cathepsin A (PPCA), a serine carboxypeptidase, forms a multienzyme complex with beta-galactosidase and neuraminidase and is required for the intralysosomal activity and stability of these two glycosidases. Genetic lesions in PPCA lead to a deficiency of beta-galactosidase and neuraminidase that is manifest as the autosomal recessive lysosomal storage disorder galactosialidosis. Eleven amino acid substitutions identified in mutant PPCAs from clinically different galactosialidosis patients have now been modeled in the three-dimensional structure of the wild-type enzyme. Of these substitutions, 9 are located in positions likely to alter drastically the folding and stability of the variant protein. In contrast, the other 2 mutations that are associated with a more moderate clinical outcome and are characterized by residual mature protein appeared to have a milder effect on protein structure. Remarkably, none of the mutations occurred in the active site or at the protein surface, which would have disrupted the catalytic activity or protective function. Instead, analysis of the 11 mutations revealed a substantive correlation between the effect of the amino acid substitution on the integrity of protein structure and the general severity of the clinical phenotype. The high incidence of PPCA folding mutants in galactosialidosis reflects the fact that a single point mutation is unlikely to affect both the beta-galactosidase and the neuraminidase binding sites of PPCA at the same time to produce the double glycosidase deficiency. Mutations in PPCA that result in defective folding, however, disrupt every function of PPCA simultaneously.
Language of Publication
English
Unique Identifier
98118562

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Carboxypeptidases|*CH/GE/ME; Lysosomal Storage Diseases|GE/*ME; Models, Molecular|*
MeSH Heading
Human; Mutation; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0027-8424
Country of Publication
UNITED STATES

Record 23 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Localization of cathepsin B in normal and hyperplastic human prostate by immunoperoxidase and protein A-gold techniques.
Author
Sinha AA; Gleason DF; Limas C; Reddy PK; Wick MR; Hagen KA; Wilson MJ
Address
Veterans Administration Medical Center Research Service, Minneapolis, Minnesota 55417.
Source
Anat Rec, 1989 Mar, 223:3, 266-75
Abstract
Cathepsin B, a lysosomal cysteine protease, was localized in normal prostate and benign prostatic hyperplasia (BPH) using immunoperoxidase and protein A-gold techniques. Our objective was to determine whether cathepsin B was involved in the prostatic epithelium affected by nodular hyperplasia. All samples were collected immediately after prostatectomy. Immunohistochemical studies showed that the enzyme was expressed in the supranuclear cytoplasm of columnar cells and in numerous basal cells of normal and BPH acini. The strongest localization of cathepsin B occurred in acinar basal cells; hence, it is possible that cathepsin B could be useful as a marker for such cellular elements. Stromal macrophages showed reaction products, but lymphocytes and neutrophils did not. In both normal and hyperplastic glands, the enzyme was localized by gold particles in lysosomes, secretory granules, and vacuoles of columnar epithelial acinar cells. Immunoelectron microscopic study also showed the presence of cathepsin B in the heterochromatin (condensed chromatin) and nuclear membranes of columnar and basal cells, but not in euchromatin or nucleoli. At present, the function of cathepsin B in the nuclei of basal and columnar cells remains unknown. However, the cathepsin B in the cytoplasmic compartment might be associated with the lysosomal function of the cells. The role of cathepsin B as a marker for basal cell participation in the development of prostatic lesions should be studied further.
Language of Publication
English
Unique Identifier
89164840

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Cathepsin B|IM/*ME; Prostate|*ME/PA
MeSH Heading
Gold|DU; Human; Hyperplasia; Immune Sera|IM; Immunoenzyme Techniques; Male; Reference Values; Staphylococcal Protein A|DU; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Tissue Distribution

Publication Type
JOURNAL ARTICLE
ISSN
0003-276X
Country of Publication
UNITED STATES

Record 24 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Progesterone and estrogen control of the response of rat uterine lysosomal cathepsin D activity to a deciduogenic stimulus.
Author
Moulton BC
Address
 
Source
Endocrinology, 1982 Apr, 110:4, 1197-202
Abstract
Endometrial sensitization to deciduogenic stimuli and destruction of luminal epithelial cells during the uterine decidual reaction may depend upon the control of endometrial lysosome function by progesterone and estradiol. These experiments examined progesterone and estrogen control of the levels of uterine cathepsin D and the response of cathepsin D activity to a deciduogenic stimulus. The progestin medroxyprogesterone acetate increased rates of uterine cathepsin D synthesis, but these rates were not enhanced by estradiol pretreatment. The response of cathepsin D activity to a deciduogenic stimulus, however, required progestin pretreatment, followed by estrogen treatment. Decreases in cathepsin D activity after a deciduogenic stimulus required estrogen stimulation for approximately 12 h, and this estrogen effect could be suppressed by treatment with dexamethasone or inhibitors of prostanoid synthesis. These results indicate that destruction of luminal epithelial cells during the uterine decidual reaction involves the coordinated control of the cathepsin D content by progesterone and of intracellular lysosome activity by estradiol.
Language of Publication
English
Unique Identifier
82138551

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Cathepsins|*ME; Decidua|*PH; Estrogens|*PD; Lysosomes|*EN; Progesterone|*PD; Uterus|*EN
MeSH Heading
Animal; Castration; Dexamethasone|PD; Estradiol|PD; Estriol|PD; Female; Meclofenamic Acid|PD; Medroxyprogesterone|AA/PD; Pseudopregnancy|EN; Rats; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0013-7227
Country of Publication
UNITED STATES

Record 25 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Urine activity of cathepsin B, collagenase and urine excretion of TGF-beta 1 and fibronectin in membranous glomerulonephritis.
Author
Senatorski G; Paczek L; Su…owicz W; Gradowska L; Bart…omiejczyk I
Address
Department of Immunotherapy, Medical University of Warsaw, Poland.
Source
Res Exp Med (Berl), 1998 Dec, 198:4, 199-206
Abstract
In 30% of cases nephrotic syndrome is caused by membranous glomerulonephritis (MG). Protein accumulation in glomeruli leads to progressive loss of kidney function and damage of structure in MG. The role of tissue proteolytic systems and growth factors in this process is not known. The purpose of the study was to estimate urine cathepsin B, collagenase activity and urine excretion of TGF-beta 1 and fibronectin in MG. Cathepsin B activity was greater in the urine of MG patients than in the control group (10.58 +/- 8.73 pmol AMC/mg creatinine per min-1 vs control 7.11 +/- 2.05 pmol AMC/mg creatinine per min-1; P < 0.05). Urine collagenase activity was higher in the group of patients than in the control group (8.59 +/- 4.26 pmol AMC/mg creatinine per min-1 vs control 3.84 +/- 2.09 pmol AMC/mg creatinine per min-1 P < 0.02). Urine excretion of fibronectin (45.60 ng/mg creatinine vs control 10.30 ng/mg creatinine; P < 0.04) and TGF-beta 1 levels in the urine were higher than in controls (283.55 +/- 248.13 pg/ml vs 36.11 +/- 48.01 pg/ml; P < 0.01). Results suggest glomerular overproduction of TGF-beta 1 and urinary leak of proteolytic enzymes (PE). This may result in decreased glomerular PE activity in MG and, with time, may lead to protein accumulation in renal glomeruli and to progressive loss of kidney function and damage of structures as the course of MG progresses. PE urine composition as well as ECM protein and cytokine urine excretion may allow noninvasive glomerulopathy course monitoring in humans in the future.
Language of Publication
English
Unique Identifier
99095671

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Cathepsin B|*UR; Collagenases|*UR; Fibronectins|*UR; Glomerulonephritis, Membranous|*UR; Transforming Growth Factor beta|BL/*UR
MeSH Heading
Adult; Female; Human; Male; Middle Age

Publication Type
JOURNAL ARTICLE
ISSN
0300-9130
Country of Publication
GERMANY

Record 26 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Structures at the proteolytic processing region of cathepsin D.
Author
Yonezawa S; Takahashi T; Wang XJ; Wong RN; Hartsuck JA; Tang J
Address
Laboratory of Protein Studies, Oklahoma Medical Research Foundation, Oklahoma City.
Source
J Biol Chem, 1988 Nov, 263:31, 16504-11
Abstract
The amino acid sequences at the "proteolytic processing regions" of cathepsin Ds have been determined for the enzymes from cows, pigs, and rats in order to deduce the sites of cleavage as well as the function of the proteolytic processing of cathepsin D. For bovine cathepsin D, the "processing region" sequence was determined from a peptide isolated from the single-chain enzyme. The COOH-terminal sequence of the light chain and the NH2-terminal sequence of the heavy chain were also determined. The processing region sequence of porcine cathepsin D was determined from its cDNA structure, and the same structure from rat cathepsin D was determined from the peptide sequence of the single-chain rat enzyme. From sequence homology to other aspartic proteases whose x-ray crystallographic structures are known, such as pepsinogen and penicillopepsin, it is clear that the processing regions are insertions to form an extended beta-hairpin loop between residues 91 and 92 (porcine pepsin numbers). However, the sizes of the processing regions of cathepsin Ds from different species are considerably different. For the enzymes from rats, cows, pigs, and human, the sizes of the processing regions are 6, 9, 9, and 11 amino acid residues, respectively. The amino acid sequences within the processing regions are considerably different. In addition, the proteolytic processing sites were found to be completely different in the bovine and porcine cathepsin Ds. While in the porcine enzyme, an Asn-Ser bond and a Gly-Val bond are cleaved to release 5 residues as a consequence of the processing; in the bovine enzyme, two Ser-Ser bonds are cleaved to release 2 serine residues. These findings would argue that the in vivo proteolytic processing of the cathepsin D single chain is probably not carried out by a specific "processing protease." Model building of the cathepsin D processing region conformation was conducted utilizing the homology between procathepsin D and porcine pepsinogen. The beta-hairpin structure of the processing region was found to (i) interact with the activation peptide of the procathepsin D in a beta-structure and (ii) place the Cys residue in the processing region within disulfide linkage distance to Cys-27 of cathepsin D light chain. These observations support the view that the processing region of cathepsin D may function to stabilize the conformation of procathepsin D and may play a role in its activation.
Language of Publication
English
Unique Identifier
89034127

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Cathepsin D|*GE; Protein Processing, Post-Translational|*
MeSH Heading
Amino Acid Sequence; Animal; Base Sequence; Cattle; Comparative Study; Computer Graphics; Human; Models, Molecular; Molecular Sequence Data; Protein Conformation; Rats; Species Specificity; Support, U.S. Gov't, P.H.S.; Swine

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES

Record 27 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G.
Author
Wintroub BU; Klickstein LB; Dzau VJ; Watt KW
Address
 
Source
Biochemistry, 1984 Jan, 23:2, 227-32
Abstract
Cathepsin G, a human lysosomal neutral protease, converts angiotensin I to angiotensin II and cleaves angiotensin II from a plasma protein substrate. Experiments were designed that identified and characterized cathepsin G substrate as human angiotensinogen. A total of 2, 5, and 10 micrograms of purified substrate, incubated with 2 microL of partially purified human renin (2 Goldblatt units/mg) for 60 min at 37 degrees C, generated 2, 9, and 22 pmol of angiotensin I. Cathepsin G substrate and renin substrate activities copurified during Affi-Gel Blue affinity chromatography, hydroxylapatite chromatography, phenyl-Sepharose chromatography, and S-200 gel filtration. Disc gel electrophoresis of 10 micrograms of purified protein gave a single band containing both activities. The amino-terminal sequence contained the covalent structure of angiotensin I and was Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-X-Glu-Ser-Thr-Cys-Gl u-. Reduced and unreduced angiotensinogens were subjected to sodium dodecyl sulfate gel electrophoresis, and each gel showed two bands of Mr 65 000 and 62 000. The isoelectric point of the Mr 65 000 form was pH 4.5-4.3 and the Mr 62 000 form was pH 4.9. Functional, structural, and physiochemical evidence demonstrates that the substrate of cathepsin G is angiotensinogen. Thus, human neutrophils may utilize angiotensin I or angiotensinogen as substrate for angiotensin II generation. The granulocyte-angiotensin system does not require renin or converting enzyme and may function as a mobile effector pathway which modulates tissue blood flow and/or vascular permeability.
Language of Publication
English
Unique Identifier
84128540

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Angiotensinogen|IP/*ME; Angiotensins|*ME; Cathepsins|*BL/IP; Granulocytes|*EN; Leukocytes|*EN
MeSH Heading
Amino Acids|AN; Human; Kinetics; Lysosomes|EN; Renin-Angiotensin System; Substrate Specificity; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-2960
Country of Publication
UNITED STATES

Record 28 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Modulation of interferon gamma induced increases in cathepsin B in THP-1 cells by adrenergic agonists and antagonists.
Author
Li Q; Bever CT Jr
Address
Departments of Neurology and Pharmacology and Experimental Therapeutics, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, 21201, USA.
Source
Cell Biol Int, 1998, 22:1, 13-20
Abstract
In order to investigate the possible modulation of macrophage function by the autonomic nervous system, the effect of adrenergic agonists and antagonists on interferon (IFN)-gamma-induced increases in cathepsin B (CB) in a macrophage-like cell line was studied. It has been shown previously that IFN-gamma induces increased CB activity in phorbol myristate acetate (PMA)-primed THP-1 cells. Isoproterenol (ISO) (10 micrometers), a mixed beta-receptor agonist, increased the induction of CB activity in the cells but norepinephrine (10 micrometers) and epinephrine (10 micrometers), the alpha and beta receptor agonists, had little effect. The addition of the mixed alpha-receptor antagonist phentolamine (10 micrometers) had no effect on ISO induced increases but the mixed beta-receptor antagonist propranolol (10 micrometers) and the selective beta1-receptor antagonist atenolol produced significant inhibition. These results suggest that the activation of beta-receptors could be involved in the induction of CB activity in macrophages and provide a possible mechanism for the regulation of macrophage effector function by the autonomic nervous system. Dibutyryl cAMP (1 mm) alone also induced increases in CB in THP-1 cells, and H-89 or HA1004 abrogated the effect of dibutyryl cAMP, suggesting that the effect of ISO on CB could be through the elevation of cAMP and the activation of cAMP-dependent protein kinases. Copyright 1998 Academic Press.
Language of Publication
English
Unique Identifier
99047439

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Adrenergic Agonists|*PD; Adrenergic Antagonists|*PD; Cathepsin B|*ME; Interferon-gamma, Recombinant|*PD
MeSH Heading
Bucladesine|PD; Cell Line; Cyclic AMP-Dependent Protein Kinases|ME; Human; Isoproterenol|PD; Macrophages|DE/EN; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Tetradecanoylphorbol Acetate|PD

Publication Type
JOURNAL ARTICLE
ISSN
1065-6995
Country of Publication
ENGLAND

Record 29 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Ontogeny, immunocytochemical localization, and biochemical properties of the pregnancy-associated uterine elastase/cathepsin-G protease inhibitor, antileukoproteinase (ALP): monospecific antibodies to a synthetic peptide recognize native ALP.
Author
Simmen RC; Michel FJ; Fliss AE; Smith LC; Fliss MF
Address
Department of Animal Science, University of Florida, Gainesville 32611.
Source
Endocrinology, 1992 Apr, 130:4, 1957-65
Abstract
Expression of the mRNA encoding the elastase/cathepsin-G protease inhibitor, antileukoproteinase (ALP), is highest in pig uterus during mid- and late pregnancy, suggesting a stage of pregnancy-dependent role for ALP in feto-maternal interactions. To elucidate a function for ALP in these events, immunogenic probes were developed to localize sites of ALP expression in the environment of the developing fetus. Monospecific antibodies raised against a 16-mer synthetic peptide corresponding to residues 21-36 (ALP 16P) of the deduced amino acid sequence of pig uterine ALP were generated by active immunization of sheep. ALP 16P conjugated to keyhole limpet hemocyanin elicited high titer antibodies that were specific to ALP. The antipeptide antibodies were used to characterize pig uterine ALP from allantoic fluids. Uterine ALP has an approximate mol wt of 14,000 and a pI of 8.2 and exhibits elastase inhibitor activity. Amino-terminal amino acid sequencing of uterine ALP indicated the sequence AENALKGGACPPRKIVQC, which has 44% identity with the corresponding region in human bronchial ALP. RIA for ALP, developed using ALP 16P as standard and iodinated tracer, demonstrated the presence of immunoreactive ALP in early, mid-, and late pregnant endometrium and myometrium, placenta, allantoic fluids, fetal cord blood, and fetal liver. ALP was undetectable in the maternal circulation. The ALP levels in endometrium, allantoic fluids, and fetal cord blood changed with the stage of pregnancy; however, ALP content in placenta, myometrium, and fetal liver, although different among tissues, remained invariant during gestation. By immunocytochemical analyses, ALP was localized in the glandular epithelium of the uterus, in placenta, and in fetal liver, consistent with the presence of immunoreactive ALP as measured by RIA. The localization of uterine ALP in placenta and its corresponding transport to fetal circulation provide strong evidence to support a physiological function for the protease inhibitor in the biological mechanisms controlling fetal development in utero.
Language of Publication
English
Unique Identifier
92191891

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Antibodies|*IM; Serine Proteinase Inhibitors|*AN/GE/IM
MeSH Heading
Amino Acid Sequence; Animal; Female; Immunohistochemistry; Maternal-Fetal Exchange; Molecular Sequence Data; Pregnancy; RNA, Messenger|AN; Sheep; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.; Swine; Uterus|CH

Publication Type
JOURNAL ARTICLE
ISSN
0013-7227
Country of Publication
UNITED STATES

Record 30 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Histochemical localization of cathepsin B at the invasion front of the rabbit V2 carcinoma.
Author
Graf M; Baici A; Sträuli P
Address
 
Source
Lab Invest, 1981 Dec, 45:6, 587-96
Abstract
To clarify the role of cathepsin B in tumor invasion, the enzyme was visualized in tissue frozen sections of the subcutaneously growing rabbit V2 carcinoma. Localization of cathepsin B was achieved by immunofluorescent staining and by enzyme histochemistry. For the former approach, a sheep antiserum was raised against purified cathepsin B from rabbit liver. The antibodies, isolated by immunoadsorption, reacted monospecifically with rabbit liver cathepsin B in Ouchterlony double diffusion and in immunoelectrophoresis. In the enzyme histochemical assay, Z-Ala-Arg-Arg-methoxynaphtylamide was used as fluorogenic substrate and nitrosalicylaldehyde as coupling agent. With both methods, cathepsin B was found to be localized within fibroblasts and leukocytes assembled at the tumor invasion front. In addition, immunofluorescent staining demonstrated the occurrence of the enzyme in the extracellular matrix surrounding tumor cell clusters. Carcinoma cells always remained unstained. The conclusion is drawn that cathepsin B is chiefly produced by host cells which are stimulated to increase synthesis and to release the enzyme under the influence of the tumor. A dual function can be ascribed to cathepsin B concentrated in the vicinity of the tumor: it operates intracellularly (in host cells) through degradation of endocytosed protein and extracellularly through activation of collagenase. The resulting lytic action on host structures appears to be a prerequisite for local spread of the V2 carcinoma.
Language of Publication
English
Unique Identifier
82102255

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Cathepsins|IM/*IP; Cell Transformation, Neoplastic|*AN/PA; Liver|*AN; Neoplasms, Experimental|*AN/PA
MeSH Heading
Animal; Antibodies; Fluorescent Antibody Technique; Histocytochemistry; Rabbits; Sheep; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0023-6837
Country of Publication
UNITED STATES

Record 31 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Direct affinity purification and supramolecular organization of human lysosomal cathepsin A.
Author
Pshezhetsky AV; Potier M
Address
Service de GÆenÆetique MÆedicale, HÈopital Sainte-Justine, MontrÆeal, QuÆebec, Canada.
Source
Arch Biochem Biophys, 1994 Aug, 313:1, 64-70
Abstract
Cathepsin A (also named "protective protein" and carboxypeptidase L) stabilizes beta-galactosidase and activates neuraminidase by forming with them a high-molecular-weight lysosomal complex. We determined the main forms of the supramolecular organization of human placental cathepsin A and the quantitative relationship between them, using an affinity chromatography on agarose-Phe-Leu for direct purification of cathepsin A. We found that cathepsin A in human placenta exists as the following three forms: a 1270-kDa complex with beta-galactosidase and neuraminidase (about 1% of total cathepsin A), a 680-kDa complex with beta-galactosidase (30-40% of total), and a free 98-kDa cathepsin A dimer (60-70% of total). All forms are in dynamic equilibrium with each other, but almost all placental beta-galactosidase is associated with cathepsin A in the 680-kDa complex. The main properties of free cathepsin A (including the capacity to associate with beta-galactosidase) were found to be identical to those of cathepsin A obtained by dissociation of the 680-kDa complex. The presence of a free cathepsin A pool in the lysosome is connected with its sixfold overproduction in the cell compared to beta-galactosidase and may be necessary to ensure cathepsin A proteolytic function in addition to its protective role for beta-galactosidase and neuraminidase in the lysosomal multienzymatic complex. Such a dual function of cathepsin A is also confirmed by our finding that it is the only carboxypeptidase of placenta extract able to catalyze the hydrolysis of both carbobenzoxy (CBZ)-Glu-Tyr and CBZ-Phe-Leu dipeptide substrates.
Language of Publication
English
Unique Identifier
94330723

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Carboxypeptidases|*CH; Cathepsins|*CH; Lysosomes|EN/*UL
MeSH Heading
beta-Galactosidase|CH; Amino Acid Sequence; Human; Macromolecular Systems; Molecular Sequence Data; Neuraminidase|CH; Placenta|EN/UL; Protein Binding

Publication Type
JOURNAL ARTICLE
ISSN
0003-9861
Country of Publication
UNITED STATES

Record 32 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Morphine induces splenocyte apoptosis and enhanced mRNA expression of cathepsin-B.
Author
Singhal PC; Reddy K; Franki N; Sanwal V; Gibbons N
Address
Department of Medicine, Long Island Jewish Medical Center, New Hyde Park, New York 11040, USA.
Source
Inflammation, 1997 Dec, 21:6, 609-17
Abstract
Morphine has been demonstrated to modulate immune function. We studied whether morphine modulates apoptosis of splenocytes. Splenocytes were isolated from control and morphine treated rats. Splenocytes isolated from morphine treated rats showed increased percentage (P < 0.001) of apoptosis when compared to splenocytes isolated from untreated rats (control, 4.7 +/- 1.0% apoptotic splenocytes/field vs. morphine, 47.8 +/- 3.4% apoptotic splenocytes/field). These results were further confirmed by gel electrophoresis as well as by end-labeling DNA of splenocytes isolated from control and morphine treated rats. Splenocytes from morphine treated rats showed a classical ladder pattern with integer multiples of 180 base pairs. Splenocytes from morphine treated rats also showed increased mRNA expression of cathepsin-B, a gene associated with active cell death. These results suggest that morphine may also be modulating immune function by enhancing apoptosis of splenocytes.
Language of Publication
English
Unique Identifier
98091743

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Apoptosis|*DE; Cathepsin B|*BI; Morphine|*PD; Narcotics|*PD; Spleen|ME/*PA
MeSH Heading
Animal; Rats; Rats, Sprague-Dawley; RNA, Messenger|BI; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0360-3997
Country of Publication
UNITED STATES

Record 33 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
The human cathepsin F gene--a fusion product between an ancestral cathepsin and cystatin gene.
Author
Wex T; Wex H; Brömme D
Address
Department of Human Genetics, Mount Sinai School of Medicine, New York, NY 10029, USA.
Source
Biol Chem, 1999 Dec, 380:12, 1439-42
Abstract
Human cathepsin F is a novel papain-like cysteine protease of unknown function. Here, we describe the complete human cathepsin F (CTSF) gene which is composed of 13 exons. In addition to a previous report, two novel upstream located exons whose splice sites interrupted the propeptide of cathepsin F within the 'cystatin-like' domain, recently described by Nagler et al. (Biochem. Biophys. Res. Comm. 257, 313-318, 1999) were identified. A comparison of the genomic structures between this novel part of the cathepsin F gene and those of several cystatin genes revealed striking similarities, supporting the hypothesis that the cathepsin F gene resulted from a gene fusion between an ancestral cystatin and cathepsin gene.
Language of Publication
English
Unique Identifier
20125514

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Cathepsins|*GE; Cystatins|*GE
MeSH Heading
Amino Acid Sequence; Exons; Human; Introns; Molecular Sequence Data; Recombinant Fusion Proteins|GE; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
1431-6730
Country of Publication
GERMANY

Record 34 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Adsorption and helical coiling of amphipathic peptides on lipid vesicles leads to negligible protection from cathepsin B or cathepsin D.
Author
Goldschmidt TG; Reyes VE; You G; Nelson DJ; Reisert PS; Anderson J; Mole J; Humphreys RE
Address
Department of Pharmacology, University of Massachusetts Medical School, Worcester 01655.
Source
Immunol Invest, 1993 Feb, 22:1, 25-40
Abstract
The processing of antigenic peptides for presentation by MHC molecules to T cells, may depend upon the function of a second, consensus sequence in or near the T cell-presented epitope. One such processing-regulating sequence appears to be composed of amino acids Leu, Ile, Val, Phe, and Met recurring in a fashion to form a longitudinal, hydrophobic strip when the excised peptide is coiled as an alpha-helix. Such a hydrophobic strip-of-helix may: (a) scavenge peptides from lumens onto lipid membranes of digestion vesicles, (b) stabilize peptides there as protease-resistant helices, (c) specify recognition by the antigenic peptide-binding sites of chaperonin proteins, transmembranal transporters, or MHC molecules. By circular dichroism and electron paramagnetic resonance, we demonstrated that peptides with recurrent hydrophobic residues potentially forming longitudinal strips adsorbed to, and partially coiled as helices on, di-O-hexadecyl, D-L-alpha-phosphatidylcholine (DHPC) vesicles. Cathepsin B or cathepsin D cleavages of three such peptides were identified. With either enzyme, it made no significant difference whether a peptide substrate was in solution or bound to vesicles in terms of efficiency and specificity of peptide bond cleavages. We conclude that protease resistance, per se, of membrane-adsorbed, helically coiled peptides is not a major factor in the selection for T cell presentation of epitopes in peptides which have a motif with a longitudinal hydrophobic strip.
Language of Publication
English
Unique Identifier
93179049

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Cathepsin B|*ME; Cathepsin D|*ME; Liposomes|*; Peptide Fragments|*CH/DE; Protein Structure, Secondary|*
MeSH Heading
Adsorption; Amino Acid Sequence; Animal; Antigen-Presenting Cells|ME; Electron Spin Resonance Spectroscopy; Molecular Sequence Data; Phospholipid Ethers; Substrate Specificity; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0882-0139
Country of Publication
UNITED STATES

Record 35 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function.
Author
Guncar G; Podobnik M; Pungercar J; Strukelj B; Turk V; Turk D
Address
Department of Biochemistry and Molecular Biology, JoÅzef Stefan Institute, Ljubljana, Slovenia. gregor.guncar@ijs.si
Source
Structure, 1998 Jan, 6:1, 51-61
Abstract
BACKGROUND: Cathepsin H is a lysosomal cysteine protease, involved in intracellular protein degradation. It is the only known mono-aminopeptidase in the papain-like family and is reported to be involved in tumor metastasis. The cathepsin H structure was determined in order to investigate the structural basis for its aminopeptidase activity and thus to provide the basis for structure-based design of synthetic inhibitors. RESULTS: The crystal structure of native porcine cathepsin H was determined at 2.1 A resolution. The structure has the typical papain-family fold. The so-called mini-chain, the octapeptide EPQNCSAT, is attached via a disulfide bond to the body of the enzyme and bound in a narrowed active-site cleft, in the substrate-binding direction. The mini-chain fills the region that in related enzymes comprises the non-primed substrate-binding sites from S2 backwards. CONCLUSIONS: The crystal structure of cathepsin H reveals that the mini-chain has a definitive role in substrate recognition and that carbohydrate residues attached to the body of the enzyme are involved in positioning the mini-chain in the active-site cleft. Modeling of a substrate into the active-site cleft suggests that the negatively charged carboxyl group of the C terminus of the mini-chain acts as an anchor for the positively charged N-terminal amino group of a substrate. The observed displacements of the residues within the active-site cleft from their equivalent positions in the papain-like endopeptidases suggest that they form the structural basis for the positioning of both the mini-chain and the substrate, resulting in exopeptidase activity.
Language of Publication
English
Unique Identifier
98154318

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Aminopeptidases|*CH; Cathepsins|*CH; Cysteine Endopeptidases|*CH
MeSH Heading
Amino Acid Sequence; Animal; Binding Sites|PH; Cathepsin B|CH; Crystallography, X-Ray; Cysteine Proteinase Inhibitors|ME; Glycosylation; Lysosomes|EN; Models, Molecular; Molecular Sequence Data; Oligosaccharides|CH; Protein Precursors|CH; Protein Processing, Post-Translational|PH; Protein Structure, Secondary; Sequence Alignment; Support, Non-U.S. Gov't; Swine

Publication Type
JOURNAL ARTICLE
ISSN
0969-2126
Country of Publication
ENGLAND

Record 36 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Characterization of recombinant rat cathepsin B and nonglycosylated mutants expressed in yeast. New insights into the pH dependence of cathepsin B-catalyzed hydrolyses.
Author
Hasnain S; Hirama T; Tam A; Mort JS
Address
Protein Structure and Design Section, National Research Council of Canada, Ottawa, Ontario.
Source
J Biol Chem, 1992 Mar, 267:7, 4713-21
Abstract
The cysteine proteinase rat cathepsin B was expressed in yeast in an active form and was found to be heterogeneously glycosylated at the consensus sequence for N-linked oligosaccharide substitution. Purified enzyme fractions containing the highest levels of glycosylation were shown to have reduced activity. A glycosylation minus mutant constructed by site-directed mutagenesis (by changing the Ser to Ala in the consensus sequence) was still secreted by the yeast and was shown to be functionally identical with purified rat liver cathepsin B. Recombinant cathepsin B was used to further characterize the pH dependence of cathepsin B-catalyzed hydrolyses using 7-amido-4-methylcoumarin (AMC) and p-nitroaniline (pNA) substrates with arginine as the P1, and either arginine or phenylalanine as the P2 residue. The AMC and pNA groups give insights into the leaving group binding site (P') of cathepsin B. These studies show for the first time that at least seven dissociable groups are involved in substrate binding and hydrolysis in cathepsin B activity. Two of these groups, with pKa values of 6.9 and 7.7 in the recombinant enzyme, are in the leaving group binding site and are most likely His110 and His111. The same groups in rat liver cathepsin B have higher pKa values than in recombinant cathepsin B, but have identical function in the two enzymes. Two other groups are probably the active site Cys29 and His199 with pKa values of 3.6 and 8.6, respectively. A group with a pKa of 5.1 interacts with substrates containing Arg at P2, and the group is most likely Glu245. The remaining two groups, one with a pKa of about 4.9 and the other about 5.3, are most likely carboxyl residues possibly interacting with Arg at P1 in the substrate. The possible candidates on the basis of the x-ray structure are Asp22, Asp69, Glu171, and Glu122, all found within a 13 A radius from the active site thiol of Cys29.
Language of Publication
English
Unique Identifier
92165832

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Cathepsin B|*GE/ME; Mutation|*; Saccharomyces cerevisiae|*EN
MeSH Heading
Animal; Catalysis; Cloning, Molecular; Electrophoresis, Polyacrylamide Gel; Gene Expression; Glycosylation; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Liver|EN; Rats; Recombinant Proteins|GE/ME; Substrate Specificity; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES

Record 37 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Adsorption and helical coiling of amphipathic peptides on lipid vesicles leads to negligible protection from cathepsin B or cathepsin D.
Author
Goldschmidt TG; Reyes VE; You G; Nelson DJ; Reisert PS; Anderson J; Mole J; Humphreys RE
Address
Department of Pharmacology, University of Massachusetts Medical School, Worcester 01655.
Source
Immunol Invest, 1993 Feb, 22:1, 25-40
Abstract
The processing of antigenic peptides for presentation by MHC molecules to T cells, may depend upon the function of a second, consensus sequence in or near the T cell-presented epitope. One such processing-regulating sequence appears to be composed of amino acids Leu, Ile, Val, Phe, and Met recurring in a fashion to form a longitudinal, hydrophobic strip when the excised peptide is coiled as an alpha-helix. Such a hydrophobic strip-of-helix may: (a) scavenge peptides from lumens onto lipid membranes of digestion vesicles, (b) stabilize peptides there as protease-resistant helices, (c) specify recognition by the antigenic peptide-binding sites of chaperonin proteins, transmembranal transporters, or MHC molecules. By circular dichroism and electron paramagnetic resonance, we demonstrated that peptides with recurrent hydrophobic residues potentially forming longitudinal strips adsorbed to, and partially coiled as helices on, di-O-hexadecyl, D-L-alpha-phosphatidylcholine (DHPC) vesicles. Cathepsin B or cathepsin D cleavages of three such peptides were identified. With either enzyme, it made no significant difference whether a peptide substrate was in solution or bound to vesicles in terms of efficiency and specificity of peptide bond cleavages. We conclude that protease resistance, per se, of membrane-adsorbed, helically coiled peptides is not a major factor in the selection for T cell presentation of epitopes in peptides which have a motif with a longitudinal hydrophobic strip.
Language of Publication
English
Unique Identifier
93179049

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Cathepsin B|*ME; Cathepsin D|*ME; Liposomes|*; Peptide Fragments|*CH/DE; Protein Structure, Secondary|*
MeSH Heading
Adsorption; Amino Acid Sequence; Animal; Antigen-Presenting Cells|ME; Electron Spin Resonance Spectroscopy; Molecular Sequence Data; Phospholipid Ethers; Substrate Specificity; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0882-0139
Country of Publication
UNITED STATES

Record 38 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Dissection of laminin by cathepsin G into its long-arm and short-arm structures and localization of regions involved in calcium dependent stabilization and self-association.
Author
Bruch M; Landwehr R; Engel J
Address
Abteilung Biophysikalische Chemie, Biozentrum der UniversitÂat, Basel, Switzerland.
Source
Eur J Biochem, 1989 Nov, 185:2, 271-9
Abstract
Native laminin-nidogen complex isolated from mouse Engelbreth-Holm-Swarm tumor was treated with purified cathepsin G or leucocyte elastase, two neutral serine proteases which play a role in inflammatory processes accompanied by degradation of basement membranes. Both enzymes were found to be more active than porcine pancreatic elastase. In the absence of Ca2+, laminin fragments produced by leucocyte elastase resembled those formed by the pancreatic enzyme but at physiological concentrations of Ca2+ cleavage by cathepsin G was much more selective. Initially laminin (900 kDa) was cleaved at two major sites only with similar rates leading to three fragments. Fragment C1-4 (about 550 kDa) comprises the intact three short arms of the molecule and fragment C8-9 (about 350 kDa) contains the entire triple-coiled region by which its three chains are assembled and the major part of the terminal globular domain of the long arm. The remaining C-terminal region of this domain was recovered as fragment C3 of about 50 kDa. Stabilization against proteolytic attack was restricted to the region of fragment C1-4 and only this fragment exhibited strong Ca2+ dependent self-association similar to that of intact laminin or of its complex with nidogen. The associative properties of fragment C1-4 were dramatically diminished upon removal of the tip of one of the short arms comprising fragment 4. In addition, this provides a clear assignment of the important laminin function to a distinct domain in one of its short arms. The new fragment C8-9 may be employed for exploring the properties and possible functions of the upper long-arm region which so far has not been available as a fragment.
Language of Publication
English
Unique Identifier
90060110

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Calcium|*ME; Cathepsins|*PD; Laminin|*ME/UL
MeSH Heading
Animal; Human; Membrane Proteins|ME; Mice; Molecular Weight; Pancreatic Elastase|PD; Peptide Fragments|ME; Protein Conformation; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0014-2956
Country of Publication
GERMANY, WEST

Record 39 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells.
Author
Weksler BB; Jaffe EA; Brower MS; Cole OF
Address
Department of Medicine, Cornell University Medical College, New York, NY.
Source
Blood, 1989 Oct, 74:5, 1627-34
Abstract
Polymorphonuclear leukocytes (PMN) when activated release products that can potentially injure endothelial cells or alter endothelial function. Exposure of cultured human umbilical vein endothelial cells to cathepsin G and elastase isolated from human PMN at concentrations reached in vivo (100 ng/mL to 10 micrograms/mL) selectively inhibited thrombin-induced prostacyclin production and the thrombin-induced rise in cytosolic free calcium ([Ca++]i) concentration. These proteases also blocked thrombin-induced release of arachidonic acid from prelabeled endothelial cells (EC). In contrast, induction of prostacyclin (PGI2) production by arachidonate, histamine, or the calcium ionophore A23187 was not altered by treatment of EC with these proteases. The effects of the proteases were concentration-dependent, were blocked by serum or serum protease inhibitors, and were reversed when the endothelial cells were further cultured for 24 hours in the absence of the proteases. Elastase, but not cathepsin G, also produced detachment of endothelial cells. Thus, the major leukocyte proteases selectively suppress thrombin-induced prostacyclin production by human vascular endothelial cells and may alter the hemostatic balance at sites of PMN activation.
Language of Publication
English
Unique Identifier
90001545

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Cathepsins|*BL/IP; Endothelium, Vascular|DE/*ME; Epoprostenol|*BI; Leukocytes|*EN; Pancreatic Elastase|*BL/IP; Thrombin|*PH
MeSH Heading
alpha 1-Antitrypsin|PH; alpha-Macroglobulins|PH; Arachidonic Acids|ME; Calcimycin|PD; Calcium|ME; Cells, Cultured; Human; Kinetics; Neutrophils|EN; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-4971
Country of Publication
UNITED STATES

Record 40 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Neutrophil elastase and cathepsin G: structure, function, and biological control.
Author
Watorek W; Farley D; Salvesen G; Travis J
Address
Department of Biochemistry, University of Georgia, Athens 30602.
Source
Adv Exp Med Biol, 1988, 240:, 23-31
Abstract
When neutrophils invade inflamed areas of the body to remove either dead or foreign components they inadvertently release potent enzymes which can, if not properly controlled, cause severe damage to healthy tissue. This can lead to a myriad of diseases including emphysema, rheumatoid arthritis, and glomuerlopnephritis, all of which are really problems of abnormal connective tissue turnover due to uncontrolled protelysis by neutrophil elastase and cathepsin G. An important step in elucidating the functions of both elastase and cathepsin G has been made by virtue of the fact that the amino acid sequence of each has been determined. Furthermore, the crystal structure of one, neutrophil elastase, is now understood. With this knowledge in mind and with the potential for a similar understanding of the mechanism of action of cathepsin G, it should soon be possible to produce synthetic inhibitors of each enzyme which can act as adjunct inhibitors to those naturally circulating in the blood or present in other tissues. As a result there is great hope for reducing the severity of injury produced by these enzymes and, therefore, in decreasing the risk for development of the debilitating diseases associated with abnormal proteolysis by neutrophil proteinases.
Language of Publication
English
Unique Identifier
89225435

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Cathepsins|*PH; Neutrophils|*EN; Pancreatic Elastase|*PH
MeSH Heading
Amino Acid Sequence; Blood Proteins; Carbohydrates|AN; Human; Molecular Sequence Data; Serine Endopeptidases|ME; Structure-Activity Relationship; Substrate Specificity; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0065-2598
Country of Publication
UNITED STATES

Record 41 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Cathepsin D inactivates cysteine proteinase inhibitors, cystatins.
Author
Lenarcic B; Kos J; Dolenc I; Lucovnik P; Krizaj I; Turk V
Address
Department of Biochemistry, J. Stefan Institute, Ljubljana, Yugoslavia.
Source
Biochem Biophys Res Commun, 1988 Jul, 154:2, 765-72
Abstract
The formation of inactive complexes in excess molar amounts of human cathepsins H and L with their protein inhibitors human stefin A, human stefin B and chicken cystatin at pH 5.6 has been shown by measurement of enzyme activity coupled with reverse-phase HPLC not to involve covalent cleavage of the inhibitors. Inhibition must be the direct result of binding. On the contrary the interaction of cystatins with aspartic proteinase cathepsin D at pH 3.5 for 60 min followed by HPLC resulted in their inactivation accompanied by peptide bond cleavage at several sites, preferentially those involving hydrophobic amino acid residues. The released peptides do not inhibit papain and cathepsin L. These results explain reported elevated levels of cysteine proteinases and lead to the proposal that cathepsin D exerts an important function, through inactivation of cystatins, in the increased activities of cysteine proteinases in human diseases including muscular distrophy.
Language of Publication
English
Unique Identifier
88293513

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Cathepsin D|*ME; Cysteine Endopeptidases|*AI; Protease Inhibitors|*; Proteins|*AI
MeSH Heading
Amino Acid Sequence; Chromatography, High Pressure Liquid; Human; Molecular Sequence Data; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0006-291X
Country of Publication
UNITED STATES

Record 42 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Cathepsin B and L in isolated proximal tubular segments during acute and chronic proteinuria.
Author
Eisenberger U; Fels LM; Olbricht CJ; Stolte H
Address
Department of Internal Medicine, Hannover Medical School, Germany.
Source
Ren Physiol Biochem, 1995 Mar, 18:2, 89-96
Abstract
Acute and chronic proteinuria were studied in rats, using lysosomal cathepsin B and L as marker enzymes for tubular protein degradation. The activity of cathepsin B and L has been determined in microdissected segments S1, S2 and S3 of the proximal tubule by an ultramicroassay. Z-Phenylalanyl-arginine-7-amido-4-methylcoumarin served as a substrate. In normoproteinuric Sprague-Dawley rats, induction of acute unselective glomerular proteinuria with Adriamycin (5 mg/kg body weight) revealed a moderate activity increase of cathepsin B and L in the S2 segment, reaching 12.6 +/- 5.6 versus 8.6 +/- 4.2 pmol.mm-1.min-1 in controls. In contrast, Munich Wistar Frömter (MWF) rats, that are characterized by a genetically determined, chronically elevated glomerular protein excretion, showed a very high activity of cathepsin selectively in S2 of 25.0 +/- 12.1 pmol.mm-1.min-1. Acute proteinuria induced by Adriamycin in chronic proteinuric MWF rats could increase cathepsin activity in the S3 segment only, showing 12.0 +/- 8.3 versus 6.8 +/- 4.0 pmol.mm-1.min-1 in MWF control rats. In conclusion, chronically increased protein filtration changes the functional reserve capacity of the proximal tubule. While acutely induced glomerular proteinuria in normoproteinuric rats stimulates lysosomal proteolytic activity mainly in S2 segment, chronic proteinuric MWF rats may display already a maximally stimulated cathepsin activity in this segment probably due to long-term increased tubular protein load. In case of acute elevation of chronic proteinuria, the consecutive S3 segment shows increased lysosomal function for protein conservation.
Language of Publication
English
Unique Identifier
95288517

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Cathepsin B|*ME; Cathepsins|*ME; Kidney Tubules, Proximal|*EN; Proteinuria|CI/GE/*ME
MeSH Heading
Acute Disease; Animal; Chronic Disease; Comparative Study; Creatinine|UR; Doxorubicin; Female; Nephrosis|CI/ME; Rats; Rats, Inbred WF; Rats, Sprague-Dawley; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
1011-6524
Country of Publication
SWITZERLAND

Record 43 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Regulation of cathepsin E expression during human B cell differentiation in vitro.
Author
Sealy L; Mota F; Rayment N; Tatnell P; Kay J; Chain B
Address
Department of Immunology, UCL Medical School, London, GB.
Source
Eur J Immunol, 1996 Aug, 26:8, 1838-43
Abstract
Cathepsin E is an aspartic proteinase which has been implicated in antigen processing in the class II major histocompatibility complex pathway. In this study we show that cathepsin E, measured at both the protein and message level, is up-regulated late in human B cell activation. The implications of this observation in terms of cathepsin E function are discussed.
Language of Publication
English
Unique Identifier
96350506

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
B-Lymphocytes|*IM/*ME; Cathepsins|*BI/GE
MeSH Heading
Adolescence; Adult; Base Sequence; Cell Differentiation|GE/IM; Cell Line; Child; Child, Preschool; Epitopes|IM; Human; Infant; Lymphocyte Transformation; Molecular Sequence Data; RNA, Messenger|AN; T-Lymphocytes|IM; Tonsil

Publication Type
JOURNAL ARTICLE
ISSN
0014-2980
Country of Publication
GERMANY

Record 44 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Expression, subcellular distribution and plasma membrane binding of cathepsin B and gelatinases in bone metastatic tissue.
Author
Arkona C; Wiederanders B
Address
Institute of Biochemistry, Medical Faculty, Friedrich-Schiller-University, Jena, Germany.
Source
Biol Chem, 1996 Nov, 377:11, 695-702
Abstract
The possible application of proteinase inhibitors in the support of anti-tumor chemotherapy requires profound knowledge of the proteinases involved in malignant processes. Therefore, the occurrence of cathepsins B, D, H, L and S and of gelatinases, urokinase plasminogen activator and stromelysins was studied in biopsies of aggressive human bone metastases, of low invading basal cell carcinomas, and in normal placenta as control, by activity measurements and zymographic techniques. Cathepsin B and L, as well as gelatinase B, were shown to be overexpressed in bone metastases, suggesting a function during the metastatic process. Subcellular fractionation allowed detection of differential sorting of cathepsin B and gelatinases in metastatic tissue and also in normal human placenta. Plasma membrane binding could be demonstrated for both cathepsin B and gelatinase B. Whereas cathepsin B is at least partially bound to plasma membranes via alpha 2-macroglobulin and its LRP/alpha 2-macroglobulin receptor, gelatinase B binds to plasma membranes by an unknown mechanism.
Language of Publication
English
Unique Identifier
97119547

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Bone Neoplasms|EN/*SC; Cathepsin B|*ME; Gelatinases|*ME
MeSH Heading
beta-N-Acetylhexosaminidase|ME; Acid Phosphatase|ME; Cathepsins|ME; Cell Membrane|EN; Collagenases|ME; Human; Lactate Dehydrogenase|ME; Neoplasm Metastasis; Phosphotransferases (Alcohol Group Acceptor)|ME; Subcellular Fractions|EN; Support, Non-U.S. Gov't; Urokinase|ME; 5'-Nucleotidase|ME

Publication Type
JOURNAL ARTICLE
ISSN
1431-6730
Country of Publication
GERMANY

Record 45 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Effects of in vitro cellular aging on alkaline phosphatase, cathepsin activities and collagen secretion of human periodontal ligament derived cells.
Author
Goseki T; Shimizu N; Iwasawa T; Takiguchi H; Abiko Y
Address
Department of Orthodontics, Nihon University School of Dentistry at Matsudo, Chiba, Japan.
Source
Mech Ageing Dev, 1996 Nov, 91:3, 171-83
Abstract
It is believed that the degree of periodontal tissue breakdown and tooth loss increase with age. In periodontal tissues which are gingiva, periodontal ligament (PL), alveolar bone and tooth cementum, the PL which is soft connective tissue, lies between the tooth cementum and alveolar bone, having the primary function of tooth support, and maintaining the homeostasis of supporting tissues, as well as providing the healing process. We therefore investigated the effects of in vitro cellular aging on alkaline phosphatase (ALP), cathepsin activities and collagen secretion from human PL cells obtained from 18-23 year-old patients' teeth. ALP, cathepsin activities and collagen secretion may play important roles in the remodeling and maintaining of periodontal tissues. To investigate the life span of PL cells, the cells were sequentially subcultivated. The maximum population doubling level of the PL cells in the present experiment was 22-25 passages. Investigating some important biological activities of the PL cells at different passage levels (6-7, 30% of life span to 17-20, 75% of life span), ALP activity and collagen secretion were found to have significantly decreased while cathepsin B and L activities significantly increased with cellular aging. Since these biological activities in human PL cells tend to be more catabolic with increase in cellular aging, the increase in periodontal breakdown with age may be partly related to the catabolic changes of the PL cells themselves.
Language of Publication
English
Unique Identifier
97208005

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Alkaline Phosphatase|*ME; Cathepsin B|*ME; Cathepsins|*ME; Collagen|*SE; Periodontal Ligament|CY/*ME
MeSH Heading
Adolescence; Adult; Cell Aging; Cell Division; Female; Human; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0047-6374
Country of Publication
IRELAND

Record 46 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
Author
Groutas WC; Chong LS; Venkataraman R
Address
Department of Chemistry, Wichita State University, KS 67260.
Source
Biochem Biophys Res Commun, 1993 Dec, 197:2, 730-9
Abstract
A series of heterocyclic compounds designed to function as mechanism-based inhibitors of human leukocyte elastase and cathepsin G has been synthesized and their inhibitory activity was investigated. These isothiazolidin-3-one derivatives were found to be effective inhibitors of cathepsin G.
Language of Publication
English
Unique Identifier
94092155

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Cathepsins|*AI/BL; Leukocytes|*EN; Pancreatic Elastase|*AI; Protease Inhibitors|CS/*PD; Thiazoles|CS/*PD
MeSH Heading
Comparative Study; Human; Kinetics; Molecular Structure; Structure-Activity Relationship; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0006-291X
Country of Publication
UNITED STATES

Record 47 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Lipid-rich residual bodies and cathepsin D in the human uterus: ultrastructural and quantitative comparison between normal myometrium and leiomyoma.
Author
Yamazaki K; Yakumaru K; Eyden BP
Address
Department of Pathology, Tokyo Teishin Hospital, Japan.
Source
J Submicrosc Cytol Pathol, 1993 Jul, 25:3, 437-47
Abstract
The lipid-rich residual bodies (LRRB) (Eyden et al., 1991) in human myometrium and uterine leiomyoma cells, have a distinctive ultrastructure characterised by a rich lipid content. To evaluate the biological or pathological significance in detail, normal myometrium and uterine leiomyoma from 30 human cases were studied by conventional histological, histochemical, immunohistochemical and electron microscopic methods. The study included a quantitative analysis of LRRBs of 3 premenarchic cases, 19 cases having a menstrual cycle, and 8 cases in menopause, in addition to 20 patients with histologically conventional leiomyoma larger than 3 cm in diameter. The study revealed the following findings: 1) immunohistochemical distribution of cathepsin D in the LRRB; 2) histochemical demonstration of neutral fat as the main content of LRRB; 3) statistically significant decrease in the distribution of LRRB in leiomyoma tissue compared with normal myometrium; 4) an absence or minimal distribution of LRRB in premenarchic myometrium; 5) a moderately significant correlation between the frequency of LRRB and patient's age. The distribution of cathepsin D within LRRB and the differential expression of LRRBs in the various smooth muscle cell tissues of the uterus suggest a possible role of ovarian hormones in the genesis of LRRBs which may function in the intra-lysosomal degradation of organelles produced during hormonal cycling.
Language of Publication
English
Unique Identifier
94006142

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Cathepsin D|*AN/ME; Inclusion Bodies|*CH/UL; Leiomyoma|*CH/PA/UL; Lipids|*AN/ME; Myometrium|*CH/CY/UL; Uterine Neoplasms|*CH/PA/UL; Uterus|*CH/CY/PA
MeSH Heading
Adolescence; Adult; Aged; Aged, 80 and over; Aging|ME/PH; Child; Comparative Study; Female; Human; Immunohistochemistry; Infant, Newborn; Menopause|PH; Menstrual Cycle|PH; Microscopy, Electron; Middle Age; Organelles|UL

Publication Type
JOURNAL ARTICLE
ISSN
1122-9497
Country of Publication
ITALY

Record 48 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Expression and partial characterization of a cathepsin B-like enzyme (Sm31) and a proposed 'haemoglobinase' (Sm32) from Schistosoma mansoni.
Author
Götz B; Klinkert MQ
Address
Institute of Cell Biology, Consiglio Nazionale delle Ricerche, Rome, Italy.
Source
Biochem J, 1993 Mar, 290 ( Pt 3):, 801-6
Abstract
Schistosoma mansoni protein Sm31 is a cysteine proteinase similar to mammalian lysosomal cathepsin B, proposed to be a key enzyme in schistosome metabolism. Protein Sm32 has been identified as a putative cysteine proteinase termed a 'haemoglobinase'. Since neither Sm31 nor Sm32 have been completely purified, some controversy of the nature of the 'true' digestive enzyme still exists. By incubating a radiolabelled cysteine-proteinase active-site-directed synthetic inhibitor with total S. mansoni proteins, the target of inhibition was Sm31 and not Sm32. The selectivity and irreversibility of inactivation make affinity labelling an invaluable tool for exploring key differences among closely related enzymes and also for studying proteinase activity in a cellular environment. In order to confirm these results, we expressed the complete cDNA sequences of Sm31 and Sm32 in insect cells and analysed the recombinant gene products for proteolytic activities. Cell extracts containing S. mansoni cathepsin B, but not those expressing 'haemoglobinase', were demonstrated to cleave a synthetic substrate benzyloxycarbonyl-arginylarginylaminomethylcoumarin in fluorescence assays. Our findings confirm previous assertions that a cysteine proteinase resembling cathepsin B is the haemoglobinase involved in digestion of host proteins. Thus, the original proposal that Sm32 is a cysteine proteinase has not been verified, and its function remains unknown.
Language of Publication
English
Unique Identifier
93207533

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Cathepsin B|CH/*GE/ME; Cysteine Endopeptidases|CH/*GE/ME; Gene Expression|*; Helminth Proteins|*GE/ME; Schistosoma mansoni|*EN
MeSH Heading
Amino Acid Sequence; Animal; Baculoviridae|GE; Binding Sites; Cell Line; Cloning, Molecular; Coumarins|ME; Dipeptides|ME; Hemoglobins|ME; Hydrolysis; Immunoblotting; Molecular Sequence Data; Moths|ME; Recombinant Proteins|CH/ME; Substrate Specificity; Support, Non-U.S. Gov't; Transfection

Publication Type
JOURNAL ARTICLE
ISSN
0264-6021
Country of Publication
ENGLAND

Record 49 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling.
Author
Scarborough PE; Guruprasad K; Topham C; Richo GR; Conner GE; Blundell TL; Dunn BM
Address
Department of Biochemistry and Molecular Biology, University of Florida, Gainesville 32610.
Source
Protein Sci, 1993 Feb, 2:2, 264-76
Abstract
The family of aspartic proteinases includes several human enzymes that may play roles in both physiological and pathophysiological processes. The human lysosomal aspartic proteinase cathepsin D is thought to function in the normal degradation of intracellular and endocytosed proteins but has also emerged as a prognostic indicator of breast tumor invasiveness. Presented here are results from a continuing effort to elucidate the factors that contribute to specificity of ligand binding at individual subsites within the cathepsin D active site. The synthetic peptide Lys-Pro-Ile-Glu-Phe*Nph-Arg-Leu has proven to be an excellent chromogenic substrate for cathepsin D yielding a value of kcat/Km = 0.92 x 10(-6) s-1 M-1 for enzyme isolated from human placenta. In contrast, the peptide Lys-Pro-Ala-Lys-Phe*Nph-Arg-Leu and all derivatives with Ala-Lys in the P3-P2 positions are either not cleaved at all or cleaved with extremely poor efficiency. To explore the binding requirements of the S3 and S2 subsites of cathepsin D, a series of synthetic peptides was prepared with systematic replacements at the P2 position fixing either Ile or Ala in P3. Kinetic parameters were determined using both human placenta cathepsin D and recombinant human fibroblast cathepsin D expressed in Escherichia coli. A rule-based structural model of human cathepsin D, constructed on the basis of known three-dimensional structures of other aspartic proteinases, was utilized in an effort to rationalize the observed substrate selectivity.
Language of Publication
English
Unique Identifier
93184744

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Cathepsin D|CH/GE/*ME; Chromogenic Compounds|CH/*ME; Oligopeptides|CH/*ME
MeSH Heading
Amino Acid Sequence; Aspartic Endopeptidases|ME; Computer Simulation; Escherichia coli|GE; Fibroblasts|EN; Human; Kinetics; Models, Molecular; Molecular Sequence Data; Placenta|EN; Protease Inhibitors|ME; Recombinant Proteins|ME; Structure-Activity Relationship; Substrate Specificity; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0961-8368
Country of Publication
UNITED STATES

Record 50 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Cathepsin B expression in human tumors.
Author
Berquin IM; Sloane BF
Address
Wayne State University, Department of Pharmacology, Detroit, Michigan 48201, USA.
Source
Adv Exp Med Biol, 1996, 389:, 281-94
Abstract
Cathepsin B has been linked to tumor progression through observations that its activity, secretion or membrane association are increased. The most malignant tumors, and specifically the cells at the invasive edge of those tumors, express the highest activity. Cathepsin B may facilitate invasion directly by dissolving extracellular matrix barriers like the basement membrane, or indirectly by activating other proteases capable of digesting the extracellular matrix. Cathepsin B also might play a role in tumor growth and angiogenesis. Cathepsin B activity is the result of several levels of regulation: transcription, post-transcription processing, translation and glycosylation, maturation and trafficking, and inhibition. The majority of reports on cathepsin B expression in tumors have focused on measurements of activity or protein staining. In some tumors, e.g. gliomas, a correlation between the amounts of cathepsin B mRNA, protein and activity and tumor progression has been established. Regulation of cathepsin B at the transcriptional and post-transcriptional levels is still poorly understood. Although the putative promoter regions have characteristics of housekeeping-type promoters, cathepsin B mRNA expression varies depending on the cell type and state of differentiation. We have evidence that more than one promoter could direct expression of human cathepsin B. Multiple transcript species have been detected, resulting from alternative splicing in the 5'- or 3'-untranslated regions, and possibly the use of alternative promoter regions. The existence of transcript variants indicates a potential for post-transcriptional control of expression. In support of this, ras-transformation of MCF-10A human breast epithelial cells results in an increase in protein levels without a concomitant increase in mRNA levels. Cathepsin B mRNA species with distinct 5'- or 3'-untranslated regions may differ in their stability and translatability. Variations in the coding region may also alter cathepsin B properties. We and Frankfater's group have observed transcript species that would encode a truncated protein, lacking the prepeptide and about half of the propeptide. This truncated protein, if synthesized in cells, would be expected to be cytosolic; therefore its function is unclear. Once the several mechanisms of regulation of cathepsin B expression and activity are better understood, they could provide us with new strategies to specifically reduce cathepsin B activity in tumors.
Language of Publication
English
Unique Identifier
97014187

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Cathepsin B|*BI/GE; Neoplasms|*EN/PA; Tumor Markers, Biological|*AN
MeSH Heading
Disease Progression; Gene Expression Regulation, Neoplastic|PH; Human; Organ Specificity; RNA, Messenger|GE; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0065-2598
Country of Publication
UNITED STATES

Record 51 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Thrombin- and cathepsin G-induced platelet aggregation: effect of protein kinase C inhibitors.
Author
Puri RN; Colman RW
Address
Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.
Source
Anal Biochem, 1993 Apr, 210:1, 50-7
Abstract
Two serine proteases, thrombin and cathepsin G, are potent agonists of human platelet activation. These pathophysiological proteases induce similar platelet responses, e.g., aggregation, shape change, and secretion of the dense granules. Maintenance of proteolytic function and the ability to bind to receptors on the platelet surface membrane are required for the responses elicited by both proteases. Protein kinase C (PKC) is a signal-transducing enzyme that is an important regulator of postreceptor intracellular changes following exposure of platelets to thrombin and cathepsin G. Inhibitors of purified PKC, e.g., staurosporine and calphostin C, have been frequently used to elucidate biochemical mechanisms mediated by the intracellular PKC following platelet activation by proteases. However, the effect of the PKC inhibitors on the amidolytic activity and on the ability of the two bioregulatory proteases to bind to cells has never been investigated. We found that staurosporine (1 and 1.5 microM), calphostin C (10 and 60 microM), and fisetin (200 and 220 microM), the three most commonly used and biochemically well-characterized inhibitors of purified PKC, completely inhibited thrombin-induced (2 nM) and cathepsin G-induced (0.85 microM) aggregation of washed human platelets, respectively. Each of the three PKC inhibitors completely blocked platelet shape change induced by thrombin (1 nM). Only fisetin inhibited platelet shape change induced by cathepsin G (0.5 microM). Only fisetin partially inhibited amidolytic activity of thrombin. The three PKC inhibitors had no inhibitory effect on the amidolytic activity of those concentrations of cathepsin G that cause maximum platelet aggregation and platelet shape change. The three PKC inhibitors completely blocked binding of 125I-thrombin to washed platelets.(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
93256284

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Cathepsins|ME/*PD; Platelet Aggregation|*DE/PH; Protein Kinase C|*AI/PH; Thrombin|ME/*PD
MeSH Heading
Alkaloids|PD; Amino Acid Sequence; Blood Platelets|CY/DE/ME; Flavones|PD; Human; In Vitro; Molecular Sequence Data; Oligopeptides|CH; Polycyclic Hydrocarbons|PD; Substrate Specificity; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0003-2697
Country of Publication
UNITED STATES

Record 52 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Processing of beta-amyloid precursor protein by cathepsin D.
Author
Higaki J; Catalano R; Guzzetta AW; Quon D; Navé JF; Tarnus C; DOrchymont H; Cordell B
Address
Scios, Inc., Mountain View, California 94043, USA.
Source
J Biol Chem, 1996 Dec, 271:50, 31885-93
Abstract
The events leading to the formation of beta-amyloid (betaA4) from its precursor (betaAPP) involve proteolytic cleavages that produce the amino and carboxyl termini of betaA4. The enzyme activities responsible for these cleavages have been termed beta- and gamma-secretase, respectively, although these protease(s) have not been identified. Since betaA4 is known to possess heterogeneity at both the amino and carboxyl termini, beta- and gamma-secretases may actually be a collection of proteolytic activities or perhaps a single proteolytic enzyme with broad amino acid specificity. We investigated the role of cathepsin D in the processing of betaAPP since this enzyme has been widely proposed as a gamma-secretase candidate. Treatment of a synthetic peptide that spans the gamma-secretase site of betaAPP with human cathepsin D resulted in the cleavage of this substrate at Ala42-Thr43. A sensitive liquid chromatography/mass spectrometry technique was also developed to further investigate the ability of cathepsin D to process longer recombinant betaAPP substrates (156 and 100 amino acids of betaAPP carboxyl terminus) in vitro. The precise cathepsin D cleavage sites within these recombinant betaAPP substrates were identified using this technique. Both recombinant substrates were cleaved at the following sites: Leu49-Val50, Asp68-Ala69, Phe93-Phe94. No cleavages were observed at putative gamma-secretase sites: Val40-Ile41 or Ala42-Thr43, suggesting that cathepsin D is not gamma-secretase as defined by these betaA4 termini. Under conditions where the betaAPP156 substrate was first denatured prior to cathepsin D digestion, two additional cleavage sites near the amino terminus of betaA4, Glu-3-Val-2 and Glu3-Phe4, were observed, indicating that cathepsin D cleavage of betaAPP is influenced by the structural integrity of the substrate. Taken together, these results indicate that in vitro, cathepsin D is unlikely to function as gamma-secretase; however, the ability of this enzyme to efficiently cleave betaAPP substrates at nonamyloidogenic sites within the molecule may reflect a role in betaAPP catabolism.
Language of Publication
English
Unique Identifier
97112979

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Amyloid beta-Protein Precursor|*ME; Cathepsin D|*ME
MeSH Heading
Amino Acid Sequence; Blotting, Western; Chromatography, High Pressure Liquid; Human; Molecular Sequence Data; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0021-9258
Country of Publication
UNITED STATES

Record 53 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Cathepsin D serum mass concentrations in patients with hepatocellular carcinoma and/or liver cirrhosis.
Author
Leto G; Tumminello FM; Pizzolanti G; Montalto G; Soresi M; Ruggeri I; Gebbia N
Address
Servizio di Chemioterapia, FacoltÄa di Medicina e Chirurgia, UniversitÄa di Palermo, Italy.
Source
Eur J Clin Chem Clin Biochem, 1996 Jul, 34:7, 555-60
Abstract
Cathepsin D serum mass concentrations were determined by enzyme immunoassay in patients with hepatocellular carcinoma (n = 51) and/or liver cirrhosis (n = 92) or benign steatosis (n = 16) and correlated with some biochemical and clinical properties of these diseases. Increased cathepsin D serum mass concentrations (P < 0.001) were observed in all these groups of patients as compared to normal subjects (n = 98). However, patients with steatosis had serum mass concentrations of this enzyme significantly lower (mean 2-3 fold) than those measured in cancer patients (P < 0.05) or cirrhotic patients (P < 0.001). Interestingly, significantly higher cathepsin D serum mass concentrations (mean + 62%) (P < 0.006) were determined in the cirrhosis group as compared to cancer patients. No correlation between cathepsin D and a number of clinical and biochemical properties examined, namely, alpha-foetoprotein, number of neoplastic lesions and tumour size in cancer patients or, Child-Pugh grade of severity of cirrhosis and other enzymes of liver function tests in the cirrhotic group was found. The present data and those from other studies which indicate that cathepsin D may be involved in carcinogenesis suggest that this enzyme may be potentially useful as an additional biochemical marker to identify cirrhotic patients who may develop precancerous hepatic nodules.
Language of Publication
English
Unique Identifier
97017787

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Carcinoma, Hepatocellular|*EN; Cathepsin D|*BL; Liver Cirrhosis|*EN; Liver Neoplasms|*EN
MeSH Heading
alpha-Fetoproteins|AN; Adult; Aged; Female; Hepatitis, Alcoholic|EN; Human; Immunoenzyme Techniques; Male; Middle Age; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0939-4974
Country of Publication
GERMANY

Record 54 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Cathepsin L proteinase secreted by Fasciola hepatica in vitro prevents antibody-mediated eosinophil attachment to newly excysted juveniles.
Author
Carmona C; Dowd AJ; Smith AM; Dalton JP
Address
School of Biological Sciences, Dublin City University, Glasnevin, Ireland.
Source
Mol Biochem Parasitol, 1993 Nov, 62:1, 9-17
Abstract
Cathepsin L-like activity was demonstrated in the excretory/secretory (E/S) products of Fasciola hepatica newly excysted juveniles (NEJ), 3-week-old, 5-week-old and mature flukes using the fluorogenic substituted 7-amino-4-methylcoumarin substrates Z-phe-arg-AMC, Z-arg-arg-AMC and Z-arg-AMC. Gelatin-substrate polyacrylamide gel analysis revealed that the E/S from each of these stages contained multiple proteolytic enzymes; however, the pattern of proteinases obtained for NEJ E/S differed markedly from that of all other stages examined. The four NEJ proteinases identified were inhibited by leupeptin and Z-phe-ala-diazomethyl ketone indicating that each had cathepsin L-like activity. The E/S products of all four developmental stages contain an enzyme capable of cleaving immunoglobulin at the hinge region, the activity of which is also inhibited by Z-phe-ala-diazomethyl ketone. Using in vitro cell attachment assays we show that the cathepsin L-like proteinase purified from the E/S products of adult F. hepatica can prevent the antibody-mediated attachment of eosinophil to NEJ. These experiments indicate that this proteinase has an important biological function in immune evasion.
Language of Publication
English
Unique Identifier
94158980

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Antibody-Dependent Cell Cytotoxicity|*; Cathepsins|IM/ME/*SE; Eosinophils|CY/*IM; Fasciola hepatica|*EN/GD/*IM
MeSH Heading
Animal; Cell Adhesion|IM; IgG|ME; In Vitro; Substrate Specificity; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0166-6851
Country of Publication
NETHERLANDS

Record 55 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells.
Author
Rochefort H; Augereau P; Briozzo P; Capony F; Cavailles V; Freiss G; Garcia M; Maudelonde T; Morisset M; Vignon F
Address
UnitÆe Hormones et Cancer, INSERM U 148, Montpellier, France.
Source
Biochimie, 1988 Jul, 70:7, 943-9
Abstract
In estrogen-receptor-positive human breast cancer cell lines (MCF7, ZR75-1), estrogens specifically increase the secretion into the culture medium of a 52,000 Da (52K) glycoprotein and stimulate cell proliferation. The 52K protein has been purified to homogeneity using monoclonal antibodies and identified as the secreted precursor of a cathepsin D bearing mannose-6-phosphate signals. The secreted precursor 52K protein is mitogenic in vitro in estrogen-deprived MCF7 cells, can be taken up by these cells via mannose-6-phosphate receptors, and can degrade extracellular matrix and proteoglycans following its auto-activation. The protease is also produced constitutively by ER-negative cell lines, and is inducible by tamoxifen in some antiestrogen-resistant variants. The corresponding cDNA has been cloned using N-terminal sequencing of the protein and monoclonal antibodies. Its complete sequencing indicates a strong homology with pro-cathepsin D of normal tissues. Using a cDNA probe, the regulation of 52K cathepsin D mRNA by estrogens and antiestrogens has been studied and chromosome localization determined by in situ hybridization. Clinical studies using both immunohistochemistry and immunoenzymatic assay of breast cancer cytosol have shown that the concentration of total cellular cathepsin D (52K + 48K + 34K) is related to the proliferation of mammary ducts and to the prognosis of breast cancer. Its cytosolic concentration in primary tumors of postmenopausal patients is correlated slightly with lymph node invasion and significantly with shorter disease-free intervals in a 6-year retrospective study with the Danish Breast Cancer Groups and Finsen Institute (S. Thorpe et al.).(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
89088285

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Breast Neoplasms|DI/*EN; Cathepsin D|GE/IP/*SE; Enzyme Precursors|GE/IP/*SE
MeSH Heading
Cell Line; Cell Transformation, Neoplastic; Estrogens|PD; Female; Human; Molecular Weight; Prognosis; Protein Processing, Post-Translational; Support, Non-U.S. Gov't; Translation, Genetic; Tumor Markers, Biological|AN

Publication Type
JOURNAL ARTICLE
ISSN
0300-9084
Country of Publication
FRANCE

Record 56 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Endometrial cathepsin D immunostaining throughout ovulatory and anovulatory menstrual cycles.
Author
Camier B; Hedon B; Rochefort H; Maudelonde T
Address
Department of Reproductive Biology, Hopital d'Amiens, France.
Source
Hum Reprod, 1996 Feb, 11:2, 392-7
Abstract
The results of histological examination of the endometrium are normal in most patients with unexplained sterility. Cathepsin D is a ubiquitous lysosomal protease regulated by progesterone in the endometrium. Assays of concentrations of cathepsin D might be useful in determining the functional responses of the endometrium to progesterone. To examine this possibility, we quantified immunostaining of endometrial cathepsin D using an image analysis system in women with regular menstrual cycles. An endometrial sample was obtained during the proliferative and luteal phases from 17 women with ovulatory menstrual cycles and at the beginning and during the last 14 days of a cycle from 15 women having anovulatory menstrual cycles. In endometrial glands of ovulatory women, cathepsin D protein immunostaining increased during the cycle and was significantly higher during the luteal than during the proliferative phase [51 +/- 38.1 arbitrary units (AU) versus 118.2 +/- 58.9 AU; P < 0.01]. This increase was also observed in stromal cells, although to a lesser extent (28.6 +/- 26.9 versus 41.5 +/- 43.1 AU; P = NS). In the endometrium of women with anovulatory menstrual cycles, cathepsin D staining was high both for the proliferative and the luteal biopsies in glands (respectively 95 +/- 43 and 104 +/- 51.3 AU) and stromal cells (respectively 61.8 +/- 33.8 and 75 +/- 32.6 AU). In women with ovulatory cycles, cathepsin D staining was localized in the apical part of glandular cells during the proliferative phase and diffused throughout the cytoplasm during the luteal phase. In contrast, in women with anovulatory cycles, cellular localization of cathepsin D remained apical in glands, regardless of the day of biopsy. In conclusion, this study shows that the cytoplasmic localization of cathepsin D might be a qualitative biological indicator of endometrial gland responses to progesterone. This could be a useful tool for evaluating cell function, which is poorly tested by histology alone.
Language of Publication
English
Unique Identifier
96256930

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Anovulation|*PP; Cathepsin D|*ME; Endometrium|CY/*ME; Menstrual Cycle|*; Ovulation|*
MeSH Heading
Adult; Female; Human; Immunohistochemistry; Staining; Support, Non-U.S. Gov't; Tissue Distribution